CN111272998A - Method for simultaneously detecting central demyelinating autoantibodies AQP4, MOG and MBP - Google Patents

Method for simultaneously detecting central demyelinating autoantibodies AQP4, MOG and MBP Download PDF

Info

Publication number
CN111272998A
CN111272998A CN202010021551.1A CN202010021551A CN111272998A CN 111272998 A CN111272998 A CN 111272998A CN 202010021551 A CN202010021551 A CN 202010021551A CN 111272998 A CN111272998 A CN 111272998A
Authority
CN
China
Prior art keywords
mog
mbp
aqp4
gene
plasmid vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010021551.1A
Other languages
Chinese (zh)
Inventor
施福东
李敏淑
金薇娜
方朝君
金立方
么阳
贾冬梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Delta Biological Technology Co ltd
Tianjin Tianhai Xinyu Biotechnology Co Ltd
Original Assignee
Zhejiang Delta Biological Technology Co ltd
Tianjin Tianhai Xinyu Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Delta Biological Technology Co ltd, Tianjin Tianhai Xinyu Biotechnology Co Ltd filed Critical Zhejiang Delta Biological Technology Co ltd
Priority to CN202010021551.1A priority Critical patent/CN111272998A/en
Publication of CN111272998A publication Critical patent/CN111272998A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Abstract

The invention discloses a method for simultaneously detecting central demyelinating autoantibodies AQP4, MOG and MBP, which comprises the following steps: respectively introducing AQP4, MOG and MBP genes into HEK293T cells, respectively incubating with a sample to be detected, detecting by an immunofluorescence method with HEK293T cells transfected with empty vectors as a control, and determining that the sample to be detected is positive if a fluorescence signal is stronger than the control; if the fluorescence signal is equal to or less than the control signal, it is negative. The method for simultaneously detecting the central demyelinating autoantibodies AQP4, MOG and MBP in the same system provided by the invention adopts a fluorescence immunocyte staining technology with higher sensitivity and specificity to be used for clinically and qualitatively detecting the AQP4, MOG and MBP antibodies, so that the detection result is more stable, and the labor and time cost is greatly saved.

Description

Method for simultaneously detecting central demyelinating autoantibodies AQP4, MOG and MBP
(I) technical field
The invention relates to detection of central demyelinating autoantibodies, in particular to a method for simultaneously detecting central demyelinating autoantibodies AQP4, MOG and MBP.
(II) background of the invention
The demyelinating disease of the central nervous system is an autoimmune system disease mainly based on multifocal and inflammatory demyelination of the central nervous system, and the clinical characteristics of the demyelinating disease mainly comprise repeated attack, repeated remission and relapse. The most common clinical demyelinating diseases of the central nervous system include Multiple Sclerosis (MS), neuromyelitis optica (NMO), acute disseminated encephalomyelitis, and the like. In recent years, the incidence of demyelinating diseases of the central nervous system tends to rise year by year, which has serious influence on the life quality of patients and poses serious threat to the physical and psychological health of patients.
The diagnosis of multiple sclerosis and neuromyelitis optica are the most common demyelinating diseases of the central nervous system, and become one of the primary diseases caused by non-traumatic disability in young and middle-aged patients, both diseases usually involve Optic nerves and spinal cords, so that clinical differentiation is difficult, particularly early onset, the research considers that the MS is autoimmune diseases mediated by CD4 helper T cells (including Th1 and Th17 subgroups), so that the treatment mainly aims at immune regulation, such as β -interferon and the like, while the NMO mainly aims at humoral immunity and mainly treats immunosuppression, so that early differential diagnosis is very important for guiding treatment and evaluation prognosis of the two diseases, the detection of Lennon and the like by an indirect immunofluorescence staining method in 2004 discovers that a specific autoantibody NMO-IgG exists in blood serum of neuromyelitis optica (Optic neuronitis, ON), the diagnosis of long-segment transverse myelitis (a pathological serodiagnosis of neuroleptic travernitis), the diagnosis of the AQO-leukoneuritis is proved by the indirect immunofluorescence staining method, the detection of the existence of a specific autoantibody in 2004, the NMO-CD-293, the serum of the monoclonal antibody, the protein.
Myelin Basic Protein (MBP), one of the major components that make up the myelin sheath of nerves, accounts for about 30% of the total myelin protein, is the most resistant protein in myelin sheath, and is synthesized and secreted by oligodendrocytes and schwann cells in the central and peripheral nervous systems, respectively. The autoimmune inflammatory response induced by anti-MBP antibodies is considered to be an important cause of a variety of neurological diseases including Multiple Sclerosis (MS). MS patients have a variety of myelin-specific antibodies, one of the important antibodies being anti-MBP antibodies. Research reports that patients with positive MBP antibodies have short remission periods and high recurrence rate compared with patients with negative MBP antibodies, and can be used as a powerful adjuvant for diagnosing MS of patients with a single demyelinating lesion; the time for a clinically confirmed isolated syndrome patient positive for an anti-MBP antibody to develop MS is shorter than that for an antibody negative patient; therefore, anti-MBP antibodies can be used as important indicators for the diagnosis of demyelinating diseases. However, the results of detection of anti-MBP antibodies are highly controversial at home and abroad. Research shows that the positive rate of the anti-MBP antibody in the MS acute phase serum is 77 percent; research also indicates that the anti-MBP antibody is related to the clinical type and course of MS, and the positive rate is only 28% in the first attack and can be increased by 60% along with the progress of the disease. The research shows that the MBP plays an important role in the differential diagnosis and the prognosis analysis of the central demyelinating disease.
The role of myelin oligodendrocyte glycoprotein immunoglobulin G antibodies (MOG-IgG) in the serum of patients with Central Nervous System (CNS) inflammatory demyelinating diseases has gradually been re-established over the past few years. While MOG antibodies have been considered to be involved in Multiple Sclerosis (MS) as a result of enzyme-linked immunosorbent assay using linearized or denatured MOG peptides as antigens, a recent new generation of cell-based assays has demonstrated that full-length, conformationally intact human MOG antibodies are closely associated with Optic Neuritis (ON), which is mostly recurrent, myelitis, brainstem encephalitis, and Acute Disseminated Encephalomyelitis (ADEM) -like manifestations, but not with classical MS. Immunological studies show that MOG-IgG has direct pathogenic effect, and serological detection shows that almost all patients positive to MOG-IgG have negative aquaporin-4 (AQP4) -IgG; the cohort study results show that its clinical presentation, adjuvant testing, treatment response and prognosis differ from that of classical MS and AQP4-IgG positive neuromyelitis optica lineage disease (NMOSD), which is considered a new disease entity known as MOG-IgG associated encephalomyelitis, abbreviated as MOG encephalomyelitis (MOG-EM). MOG-EM and MS share some similarities and their clinical and imaging manifestations often overlap: as with MOG-EM, most patients relapse, and in addition, 33% and 15% of adult MOG-EM patients meet the McDonald and Barkhof diagnostic criteria for MS at least once during the course of the disease, and thus many MOG-EM patients have been misdiagnosed as MS in the past, whereas serological tests that bind the AQP4 antibody and the MOG antibody will aid in the differential diagnosis of MS.
Currently, the international technologies for detecting AQP-4 antibody mainly include indirect immunofluorescence Assay (IIF), Fluoroimmunoprecipitation Assay (FIPA), Radioimmunoprecipitation Assay (RIPA), Cell-based Assay (CBA) (Clin Immunol.2011Mar; 138(3):239-46, Neurology.2012Feb 28; 78(9):665-71) and Enzyme-Linked ImmunoSorbent Assay (ELISA). The traditional method for detecting AQP-4, such as indirect immunofluorescence method, enzyme linked immunosorbent assay and the like, has low sensitivity and specificity, and the radioimmunoprecipitation method relates to the problem of radioactive source pollution. The plasmids used in the traditional CBA method were the EGFP-tagged human AQP4 cDNA plasmid and a control EGFPcDNA plasmid, and transient transfection was performed using Polyethyleneimine (PEI) or liposome methods. The time consumption is long, the manpower and material resources are greatly consumed, the fluorescence efficiency is unstable, and a more stable transfection method is needed to obtain more sensitive and stable results. Most of MOG and MBP autoantibody detection uses a nerve tissue section with high expression of MBP antigen for staining detection, and the method has a plurality of problems, such as large difference among batches due to the difficulty in controlling the tissue section; most of the tissue slices are animal sources (such as monkey nerve tissue slices used by European Union), and the antigens have species differences, so that the sensitivity and specificity of detection are reduced; the presence of antigens other than MBP in the tissue, a positive result of the test may not be positive for MBP antibody. 2. The Western method or the Elisa method has the advantages that although the two techniques are mature, the spatial conformation of the MBP antigen is difficult to maintain, so that the specificity is low, the cost is high, and the popularization of the detection means is greatly limited.
Disclosure of the invention
The invention aims to provide a method for simultaneously detecting central demyelinating autoantibodies AQP4, MOG and MBP by applying an immunofluorescence technique, wherein a cell line stably transfected with AQP-4, MOG and MBP is coated on the same glass slide, and the AQP-4, MOG and MBP antibodies are simultaneously and qualitatively detected by adopting a fluorescence immunocyte staining method (CBA) detection technique with higher sensitivity and specificity, so that the detection result is more stable, the labor and time cost is greatly saved, and the clinical diagnosis and treatment level of neuromyelitis optica and multiple sclerosis is favorably improved.
The technical scheme adopted by the invention is as follows:
the invention provides a method for simultaneously detecting central demyelinating autoantibodies AQP4, MOG and MBP, which comprises the following steps: respectively introducing AQP4, MOG and MBP genes into HEK293T cells (namely an HEK293T cell line containing AQP-4 genes, an HEK293T cell line containing MBP genes and an HEK293T cell line containing MOG genes), respectively incubating with a sample to be detected, detecting by adopting an immunofluorescence method by taking HEK293T cells transfected with empty carriers as a control, and if the fluorescence signal of the sample to be detected is stronger than that of the control, determining that the sample to be detected is positive; if the fluorescence signal is equal to or less than the control signal, it is negative.
Further, the detection method comprises the following steps: (1) mixing the cell adherence reagent and PBS according to the volume ratio of 1:10, adding the mixture into a 6-well plate containing a cover glass, and keeping the temperature at 37 ℃ and 5% CO2Incubating for 1 hour; then adding a stable HEK293T cell line which is respectively transferred with AQP4, MOG and MBP genes, wherein the cell inoculation amount is 1 multiplied by 106/ml,37℃,5%CO2Culturing to 80% fusion degree;
(2) the cover glass (preferably cutting the cover glass to a small square with the side length of 5 mm) with the cell surface facing upwards is pasted on the glass slide (preferably shadowless glue is pasted, and ultraviolet irradiation is carried out for 30 seconds for pasting), and the cover glass is a reaction area; PBST wash (preferably 50 ul/reaction zone, 5 minutes wash); blocking with 3% BSA (preferably 50 ul/reaction zone for 30 min) and discarding; adding test serum (preferably 50 μ l per well) diluted by PBST at a volume ratio of 1:10, and adding 5% CO at 37 deg.C2Incubating for 1 hour under the condition; PBST wash (preferably 3 times for 5 minutes each); goat anti-human (Biotin-SP-conjugated Affinipure goat coat anti-human IgG) (preferably 50. mu.l per well) with Biotin conjugated to streptomycin diluted in PBST at a volume ratio of 1:700 was added at 37 ℃ with 5% CO2Incubating for 30 minutes under the condition; PBST wash (preferably 3 times for 5 minutes each);add the fluorescein 488 monthly streptomycin conjugate (Alex fluor 488-conjugated streptavidin) diluted by PBST at a volume ratio of 1:700 (preferably 50. mu.l per well), PBST wash (preferably 3 times, 5 minutes each); sealing by using a sealing agent; HEK293T cells transfected with the empty vector were used as controls under the same conditions; then, carrying out fluorescence microscope detection, and if the fluorescence signal is stronger than the contrast, determining that the sample to be detected is positive; if the fluorescence signal is equal to or less than the control signal, it is negative.
Further, the AQP4, MOG and MBP genes are respectively introduced into HEK293T cells in a form of lentiviral plasmid vectors, and the nucleotide sequence of the lentiviral plasmid vector containing the AQP4 gene is shown in SEQ ID NO. 1; the nucleotide sequence of the slow virus plasmid vector containing the MBP gene is shown in SEQ ID NO. 2; the nucleotide sequence of the lentiviral plasmid vector containing the MOG gene is shown in SEQ ID NO. 3.
Compared with the prior art, the invention has the following beneficial effects: the method for simultaneously detecting the central demyelinating autoantibodies AQP4, MOG and MBP in the same system provided by the invention adopts a fluorescence immunocyte staining technology with higher sensitivity and specificity to be used for clinically and qualitatively detecting the AQP4, MOG and MBP antibodies, so that the detection result is more stable, and the labor and time cost is greatly saved. The establishment of a platform of the central demyelination autoantibody detection technology is beneficial to improving the clinical diagnosis and treatment level of neuromyelitis optica and multiple sclerosis. The antibody detection is an important diagnosis index of autoimmune diseases, and the establishment of the item can greatly improve the disease spectrum of neuromyelitis optica and the diagnosis and treatment level of multiple sclerosis, improve the labor capacity and the life quality of patients and generate great social and economic benefits.
(IV) description of the drawings
FIG. 1 is a schematic representation of the construction of the AQP4 viral vector.
FIG. 2 is a schematic diagram of the construction of MBP viral vectors.
FIG. 3 is a schematic diagram of the construction of MOG viral vectors. .
FIG. 4 is an AQP-4 protein expression electrophoresis diagram after the AQP-4 virus expression vector is infected by HEK293 cells.
FIG. 5 is an electrophoresis diagram of MOG protein expression after HEK293 cells are infected with MOG virus expression vectors.
FIG. 6 shows the MBP protein level expression electrophoretogram (A) and fluorometric chart (B) in MBP plasmid-transfected cells.
FIG. 7 is a fluorescence diagram of AQP-4/MOG/MBP antibody expression level of serum to be detected by cell immunofluorescence assay.
(V) detailed description of the preferred embodiments
The invention will be further described with reference to specific examples, but the scope of the invention is not limited thereto:
example 1 construction of Stable HEK293T cells transfected with AQP4, MOG, MBP genes
1. Vector construction:
(1) construction of overexpression vector fusing and expressing human AQP-4 gene and fluorescence labeling gene EGFP
Using pEGFP-N1 vector as template, adopting primers EGFP and EGFP to amplify EGFP sequence, wherein the primers are as follows: 5'-CTA GGATCC ATGGTGAGCAAGGGCGAGGAG-3' and 5'-CAGGTCGACGAATTCGCGGCCGCCTCGAGCTGCAGTTACTTGTACAGCTCGTCCATGCCG-3' of EGPF, cutting the amplified fragment into gel, recovering the gel, connecting the gel with a T vector, performing double enzyme digestion by BamHI and SalI after the sequence is aligned to be correct, connecting the gel with a pCDH-CMV-MCS-EF1-CopGFP vector fragment subjected to double enzyme digestion by the same enzyme, and replacing an EF1-copGFP sequence in the original vector by EGFP to obtain a plasmid vector pCDH-CMV-MCS-EGFP.
The AQP-4(M1+ M23) sequence is amplified by PCR by using human optic nerve cDNA as a template and AQP4F and AQP4R as primers to obtain an AQP-4 amplified fragment.
AQP4F:5’-ACTTCTAGAATGAGTGACAGACCCACAGCAAG-3’;
AQP4R:5’-CCAAGATCTTGAACCGCCTCCACCTACTGAAGACAATACCTCT CCAGATTG-3’。
Cutting gel of the AQP-4 amplified fragment, recovering the gel, connecting the gel with a T vector, performing sequencing comparison to obtain a correct sequence, performing double enzyme digestion on the gel by EcoRI and XhoI, and connecting the gel with a vector pLV-Puro subjected to double enzyme digestion by EcoRI and XhoI to obtain a vector pLV-Puro-AQP-4; then XbaI and BglII are used for double enzyme digestion and then are connected with the obtained plasmid vector pCDH-CMV-MCS-EGFP to obtain the lentiviral plasmid vector pLenti-CMV-AQP-4-EGFP, the nucleotide sequence is shown in SEQ ID NO.1, and the plasmid is shown in FIG. 1.
(2) Construction of overexpression vector fusing and expressing human MBP gene and fluorescence labeling gene EGFP
Using human oligodendrocyte as template (
Figure BDA0002360946550000041
CRL-3216TM) And carrying out PCR amplification on the MBP sequence by taking MBP F and MBP R as primers.
MBP F:5’-TTTCTAGAAATGTACAAGGAATTCGCCACCATGGCGTCACAGAAGA-3’;
MBP R:5’-TCTAGGGATCCGGGCCCGGGTTCGAACTCGAGTCAGCGTCTAGCCATGGGT-3’。
And (2) cutting the MBP amplified fragment into gel, recovering the gel, connecting the gel with a T vector, performing sequencing comparison to obtain a correct sequence, performing double enzyme digestion on the gel by using EcoRI and XhoI, connecting the gel with a vector pLV-Puro subjected to double enzyme digestion by using EcoRI and XhoI to obtain a vector pLV-Puro-MBP, performing double enzyme digestion on the gel by using XbaI and BglII, and connecting the gel with the plasmid vector pCDH-CMV-MCS-EGFP obtained in the step (1) to obtain the lentiviral plasmid vector pLV-EGFP (2) Puro-MBP-V1, wherein the nucleotide sequence is shown in SEQ ID NO.2, and the plasmid is shown in FIG. 2.
(3) Construction of overexpression vector fusing and expressing human MOG gene and fluorescence labeling gene EGFP
Using human oligodendrocyte as template (
Figure BDA0002360946550000051
CRL-3216TM) And carrying out PCR amplification on the MOG sequence by taking MOG F and MOG R as primers.
MOG F:5’-GGGTAGTTTAGAGTGATAGGATTAAGATAT-3’;
MOG R:5’-TAAAAATAAACCACCCTAAAAAAAA-3’
And (3) carrying out electrophoresis on the amplified fragment, cutting and recovering the gel, connecting the recovered gel with a T vector, carrying out sequencing comparison, confirming the correct sequence, carrying out double enzyme digestion on the obtained product by EcoRI and XhoI, and connecting the obtained product with a pCDH-CMV-MCS-EGFP particle vector to obtain a lentiviral plasmid vector pLenti-CMV-MOG-EGFP for over-expressing the human MOG full-length gene, wherein the nucleotide sequence is shown as SEQ ID NO.3, and the plasmid is shown as figure 3.
2. Viral packaging and acquisition of HEK293T stably transfected cell line
By using CaCl2Packaging lentivirus expressing target gene fusion protein, collecting virus suspension, infecting HEK293 cells in the presence of Polybrene (Polybrene) of 6 μ g/ml, and after 1 week, sorting positive stable transfected cells. After continuous subculture, secondary screening is carried out to obtain a 100% transfected HEK293 cell line stably expressing the fusion protein, which specifically comprises the following steps:
1) cell culture: inoculating HEK293T cell line of human embryonic kidney into low-sugar DMEM medium containing 10% inactivated fetal calf serum, and placing at 37 deg.C and 5% CO2Culturing in an incubator, taking HEK293T cells in logarithmic growth phase, resuspending the cells in a low-sugar DMEM medium containing 10% of inactivated Fetal Bovine Serum (FBS) and 1% of double antibodies (penicillin and streptomycin with final concentration of 100 mu g/mL), and preserving in liquid nitrogen in a freezing tube for experiment;
2) recovery and passage of cells: taking out the frozen tube obtained in the step 1), quickly putting the frozen tube into a water bath at 37 ℃ and continuously shaking the frozen tube to thaw the frozen tube in the shortest time, sterilizing the outer surface of the frozen tube by 70% alcohol, transferring the cell sap in the frozen tube into a 50ml centrifuge tube filled with 20ml of low-sugar DMEM medium, centrifuging the cell sap for 5 minutes at 1000rmp, removing the supernatant, depositing the cell sap in the low-sugar DMEM medium containing 10% fetal calf serum, and removing 5% CO at 37 ℃ to obtain a precipitate2Culturing under saturated humidity until the confluence reaches 80%;
3) digestion of cells: adding 1ml of pancreatin into step 2), digesting HEK293T cells for 1-2 min, collecting HEK293T cells, resuspending with low sugar DMEM medium containing 10% FBS, placing in a culture dish, and adding 5% CO2Incubation is carried out in an incubator at 37 ℃ for 24 hours, and transfection can be started when the cells are completely attached. The medium was changed 2 hours before transfection (1.5 ml of complete medium was used to replace the old medium).
4) Plasmid transfection: a sterile 1.5ml EP tube was put in 400. mu.l of serum-free low-sugar DMEM medium, 6. mu.l of mixed plasmid (target plasmid: packaged plasmid VSVG: packaged plasmid REV: 5:3:2, volume ratio) and 6. mu.l of transfection reagent (Lipofectamine 2000) were added, and the mixture was mixed well and allowed to stand for 15 minutes to obtain 412. mu.l of plasmid mixture. Adding 412 μ l of plasmid mixed solution dropwise into the culture dish with complete adherence in the step 3)Gently shaking the culture dish, mixing well, and placing in a container containing 5% CO2At 37 ℃ in an incubator. Wherein the target plasmids are respectively a lentivirus plasmid vector pLenti-CMV-AQP-4-EGFP, a lentivirus plasmid vector pLV-EGFP (2) Puro-MBP-V1 and a lentivirus plasmid vector pLenti-CMV-MOG-EGFP.
5) And (3) virus collection: step 4) after 8 hours incubation, the medium was aspirated, 2.5ml of low sugar DMEM medium pre-heated at 37 ℃ was added, and the incubation continued with 5% CO2Incubating at 37 ℃ for 40 hours in an incubator, collecting the culture solution into a 1.5ml centrifuge tube, centrifuging at 3000rpm for 20 minutes, filtering the supernatant by a 0.45 mu m filter head, and collecting the filtrate, namely the virus solution, to respectively obtain AQP-4 virus solution, MBP virus solution and MOG virus solution. Subpackaging and storing at-80 deg.C for use.
6) Virus titer determination (dilution count method):
titer unit: TU/ml, refers to the number of biologically active viral particles contained per ml. "TU" is an abbreviation for "transducing units" and in Chinese "transducing units" and represents the number of viral genomes that can infect and enter target cells.
First day cell preparation: digesting and counting HEK293T cells with good growth state in the step 2), and diluting to 1 × 10 by using low-sugar DMEM medium5Adding into 96-well plate (100 ul/well), dividing into 3 groups (AQP-4 virus solution, MBP virus solution, and MOG virus solution), preparing 10 wells, placing at 37 deg.C and 5% CO2Culturing in an incubator.
The next day, virus addition: 10-fold gradient dilutions were made in EP tubes, 10 dilutions in series, as follows: preparing 10 EP tubes of 1.5ml for each group of viruses, adding 90ul of DMEM culture solution containing 10% inactivated fetal calf serum and 1% double antibody into each tube, adding 10ul of the virus solution prepared in the step 5) into the first tube, uniformly mixing, sucking 10ul of the virus solution, adding the virus solution into the second tube, and uniformly mixing. Repeating the above steps until ten dilutions (10-10)-8). The original medium in the 96-well plate was aspirated, and an equal volume of diluted virus solution was added and labeled.
And (3) adding culture solution on the third day: 100ul of low-sugar DMEM medium was added to each well and cultured for 48 hours to the fifth day.
Results were observed and titers calculated on day five: the results were observed under a fluorescent microscope and the number of the last two fluorescent cell clones were counted, assuming X and Y, the titer (TU/ml) was (X + Y × 10) × 1000/2/X well virus content (ul).
7) Virus infection and stable cell line screening: 8ul of virus liquid in the step 5) and PEG8000 according to the volume ratio of 4: 1, every 20 minutes, 4 times, 4 ℃ overnight. The next day, centrifugation was carried out at 4000g and 4 ℃ for 20 minutes, the supernatant was discarded, and 100ul of virus concentrate was obtained by resuspending the pellet in 100ul of DMEM medium containing 10% inactivated fetal calf serum and 1% double antibody. 10ul of virus concentrate containing 6. mu.g/ml polyamine were added to HEK293T cells in logarithmic growth phase from step 1), after 48 hours a final concentration of 15ug/ml puromycin was added, fresh medium was replaced approximately every 2 days at 37 ℃ with 5% CO2Culturing for about 10 days, sorting the positive stable high expression transfected cells of the protein to be detected by using single cell clone, respectively obtaining HEK293T cells of a transfected gene AQP4, HEK293T cells of a transfected gene MOG and HEK293T cells of a transfected gene MBP, and measuring the relative expression amount and protein level expression of the target antibody transcript in the screened cells and the untransfected 293T cells by using quantitative PCR and western blot technology, as shown in figure 4, figure 5 and figure 6. The results show that the transcripts of the target antibodies (AQP4, MOG, MBP) were significantly increased in the stably transfected cell lines compared to the untransfected 293T cells.
Example 2 measurement of serum AQP4, MOG, MBP antibodies by immunofluorescence staining method
1) Inoculating cells: mixing cell adherence reagent (purchased from Beijing Fine engineering Biotech Co., Ltd., product number: 1027) and PBS at volume ratio of 1:10, adding into 6-well plate containing cover glass, and heating at 37 deg.C with 5% CO2And incubated for 1 hour. Then adding stable HEK293T cell lines (namely HEK293T cell line containing AQP-4 gene, HEK293T cell line containing MBP gene and HEK293T cell line containing MOG gene) respectively transferred with AQP4, MOG and MBP genes, wherein the cell inoculation amount is 1 × 106/ml,37℃,5%CO2Cultured to 80% confluence for subsequent testing. HEK293T cells transfected with the empty vector were used as controls under the same conditions.
2) Cellular immunofluorescence: cutting the cover glass with a diamond lettering pen to a small square with the side length of 5mm, enabling the cell surface to face upwards, adhering the shadowless glue on the glass slide, and firmly adhering the cover glass after ultraviolet irradiation for 30 seconds, wherein the cover glass is the reaction area. PBST washed cells 50 ul/reaction zone for 5 min. Blocked with 3% BSA at 50 ul/reaction area for 30 min and discarded. 50 mul of serum to be tested diluted by PBST at a volume ratio of 1:10 is respectively added into corresponding holes, and 5 percent CO is added at 37 DEG C2Incubate under conditions for 1 hour. PBST was washed 3 times for 5 minutes each. 50 μ l of goat anti-human (Biotin-SP-conjugated Affinipure goat anti-human IgG) diluted with PBST at a volume ratio of 1:700 was added to each dilution, and 5% CO was added at 37 ℃2Incubate under conditions for 30 minutes. PBST was washed 3 times for 5 minutes each. 50. mu.l of fluorescein 488 monthly streptomycin conjugate (Alex fluor 488-conjugated streptavidin) diluted with PBST at a volume ratio of 1:700 was added, respectively. PBST was washed 3 times for 5 minutes each. The sealing agent seals the sheet.
3) Fluorescence microscopy analysis: the relative amount of antibody concentration was indicated by the intensity of red fluorescence signal in a 20-fold field of the objective lens with the control of cells transfected with empty vector. The results show that the method of the present invention can distinguish the relative amounts of autoantibodies in AQP4, MOG, MBP positive patients based on fluorescence intensity, as shown in figure 7.
Example 3 specific detection
In view of the low positive rate of the MOG antibody detection, in order to further promote the clinical application of the method, 120 sera of patients with nervous system diseases are selected by multiple centers and are respectively sent to European Union third-party companies for detection, and meanwhile, the detection method is used for blind detection. The detection rate of the MOG positive antibody of the method is analyzed by comparing with the EU detection method.
120 sera of patients with neurological diseases (30 patients with demyelinating diseases) were selected and compared with the detection rate of the method of the present invention (example 2) using the detection method of Europe (Europe medical diagnostics, China, Inc.). The results showed that in 4 out of 30 demyelinated patients, omron detected MOG antibody positive sera, 6 positive sera were detected by the present detection method, and the patients with the detected MOG positive sera were central demyelinating diseases and were in accordance with clinical symptoms. In the other 90 cases of non-demyelinated patients, the results of the omron test and the test by the method were negative.
Sequence listing
<110> Tianjin Tianhai New zone Biotechnology, Inc., Zhejiang Damei Biotechnology, Inc
<120> a method for simultaneously detecting central demyelinating autoantibodies AQP4, MOG and MBP
<160>3
<170>SIPOSequenceListing 1.0
<210>1
<211>1710
<212>DNA
<213> Unknown (Unknown)
<400>1
atgagtgaca gacccacagc aaggcggtgg ggtaagtgtg gacctttgtg taccagagag 60
aacatcatgg tggctttcaa aggggtctgg actcaagctt tctggaaagc agtcacagcg 120
gaatttctgg ccatgcttat ttttgttctc ctcagcctgg gatccaccat caactggggt 180
ggaacagaaa agcctttacc ggtcgacatg gttctcatct ccctttgctt tggactcagc 240
attgcaacca tggtgcagtg ctttggccat atcagcggtg gccacatcaa ccctgcagtg 300
actgtggcca tggtgtgcac caggaagatc agcatcgcca agtctgtctt ctacatcgca 360
gcccagtgcc tgggggccat cattggagca ggaatcctct atctggtcac acctcccagt 420
gtggtgggag gcctgggagt caccatggtt catggaaatc ttaccgctgg tcatggtctc 480
ctggttgagt tgataatcac atttcaattg gtgtttacta tctttgccag ctgtgattcc 540
aaacggactg atgtcactgg ctcaatagct ttagcaattg gattttctgt tgcaattgga 600
catttatttg caatcaatta tactggtgcc agcatgaatc ccgcccgatc ctttggacct 660
gcagttatcatgggaaattg ggaaaaccat tggatatatt gggttgggcc catcatagga 720
gctgtcctcg ctggtggcct ttatgagtat gtcttctgtc cagatgttga attcaaacgt 780
cgttttaaag aagccttcag caaagctgcc cagcaaacaa aaggaagcta catggaggtg 840
gaggacaaca ggagtcaggt agagacggat gacctgattc taaaacctgg agtggtgcat 900
gtgattgacg ttgaccgggg agaggagaag aaggggaaag accaatctgg agaggtattg 960
tcttcagtag gtggaggcgg ttcaagatcc atggtgagca agggcgagga gctgttcacc 1020
ggggtggtgc ccatcctggt cgagctggac ggcgacgtaa acggccacaa gttcagcgtg 1080
tccggcgagg gcgagggcga tgccacctac ggcaagctga ccctgaagtt catctgcacc 1140
accggcaagc tgcccgtgcc ctggcccacc ctcgtgacca ccctgaccta cggcgtgcag 1200
tgcttcagcc gctaccccga ccacatgaag cagcacgact tcttcaagtc cgccatgccc 1260
gaaggctacg tccaggagcg caccatcttc ttcaaggacg acggcaacta caagacccgc 1320
gccgaggtga agttcgaggg cgacaccctg gtgaaccgca tcgagctgaa gggcatcgac 1380
ttcaaggagg acggcaacat cctggggcac aagctggagt acaactacaa cagccacaac 1440
gtctatatca tggccgacaa gcagaagaac ggcatcaagg tgaacttcaa gatccgccac 1500
aacatcgagg acggcagcgt gcagctcgcc gaccactacc agcagaacac ccccatcggc 1560
gacggccccg tgctgctgcc cgacaaccac tacctgagca cccagtccgc cctgagcaaa 1620
gaccccaacg agaagcgcga tcacatggtc ctgctggagt tcgtgaccgc cgccgggatc 1680
actctcggca tggacgagct gtacaagtaa 1710
<210>2
<211>9496
<212>DNA
<213> Unknown (Unknown)
<400>2
tggaagggct aattcactcc caaagaagac aagatatcct tgatctgtgg atctaccaca 60
cacaaggcta cttccctgat tagcagaact acacaccagg gccaggggtc agatatccac 120
tgacctttgg atggtgctac aagctagtac cagttgagcc agataaggta gaagaggcca 180
ataaaggaga gaacaccagc ttgttacacc ctgtgagcct gcatgggatg gatgacccgg 240
agagagaagt gttagagtgg aggtttgaca gccgcctagc atttcatcac gtggcccgag 300
agctgcatcc ggagtacttc aagaactgct gatatcgagc ttgctacaag ggactttccg 360
ctggggactt tccagggagg cgtggcctgg gcgggactgg ggagtggcga gccctcagat 420
cctgcatata agcagctgct ttttgcctgt actgggtctc tctggttaga ccagatctga 480
gcctgggagc tctctggcta actagggaac ccactgctta agcctcaata aagcttgcct 540
tgagtgcttc aagtagtgtg tgcccgtctg ttgtgtgact ctggtaacta gagatccctc 600
agaccctttt agtcagtgtg gaaaatctct agcagtggcg cccgaacagg gacttgaaag 660
cgaaagggaa accagaggag ctctctcgac gcaggactcg gcttgctgaa gcgcgcacgg 720
caagaggcga ggggcggcga ctggtgagta cgccaaaaat tttgactagc ggaggctaga 780
aggagagaga tgggtgcgag agcgtcagta ttaagcgggg gagaattaga tcgcgatggg 840
aaaaaattcg gttaaggcca gggggaaaga aaaaatataa attaaaacat atagtatggg 900
caagcaggga gctagaacga ttcgcagtta atcctggcct gttagaaaca tcagaaggct 960
gtagacaaat actgggacag ctacaaccat cccttcagac aggatcagaa gaacttagat 1020
cattatataa tacagtagca accctctatt gtgtgcatca aaggatagag ataaaagaca 1080
ccaaggaagc tttagacaag atagaggaag agcaaaacaa aagtaagacc accgcacagc 1140
aagcggccgg ccgctgatct tcagacctgg aggaggagat atgagggaca attggagaag 1200
tgaattatat aaatataaag tagtaaaaat tgaaccatta ggagtagcac ccaccaaggc 1260
aaagagaaga gtggtgcaga gagaaaaaag agcagtggga ataggagctt tgttccttgg 1320
gttcttggga gcagcaggaa gcactatggg cgcagcgtca atgacgctga cggtacaggc 1380
cagacaatta ttgtctggta tagtgcagca gcagaacaat ttgctgaggg ctattgaggc 1440
gcaacagcat ctgttgcaac tcacagtctg gggcatcaag cagctccagg caagaatcct 1500
ggctgtggaa agatacctaa aggatcaaca gctcctgggg atttggggtt gctctggaaa 1560
actcatttgc accactgctg tgccttggaa tgctagttgg agtaataaat ctctggaaca 1620
gatttggaat cacacgacct ggatggagtg ggacagagaa attaacaatt acacaagctt 1680
aatacactcc ttaattgaag aatcgcaaaa ccagcaagaa aagaatgaac aagaattatt 1740
ggaattagat aaatgggcaa gtttgtggaa ttggtttaac ataacaaatt ggctgtggta 1800
tataaaatta ttcataatga tagtaggagg cttggtaggt ttaagaatag tttttgctgt 1860
actttctata gtgaatagag ttaggcaggg atattcacca ttatcgtttc agacccacct 1920
cccaaccccg aggggacccg acaggcccga aggaatagaa gaagaaggtg gagagagaga 1980
cagagacaga tccattcgat tagtgaacgg atctcgacgg tatcgccttt aaaagaaaag 2040
gggggattgg ggggtacagt gcaggggaaa gaatagtaga cataatagca acagacatac 2100
aaactaaaga attacaaaaa caaattacaa aaattcaaaa ttttcgggtt tattacaggg 2160
acagcagaga tccagtttat cgataagctt gggagttccg cgttacataa cttacggtaa 2220
atggcccgcc tggctgaccg cccaacgacc cccgcccatt gacgtcaata atgacgtatg 2280
ttcccatagt aacgccaata gggactttcc attgacgtca atgggtggag tatttacggt 2340
aaactgccca cttggcagta catcaagtgt atcatatgcc aagtacgccc cctattgacg 2400
tcaatgacgg taaatggccc gcctggcatt atgcccagta catgacctta tgggactttc 2460
ctacttggca gtacatctac gtattagtca tcgctattac catggtgatg cggttttggc 2520
agtacatcaa tgggcgtgga tagcggtttg actcacgggg atttccaagt ctccacccca 2580
ttgacgtcaa tgggagtttg ttttggcacc aaaatcaacg ggactttcca aaatgtcgta 2640
acaactccgc cccattgacg caaatgggcg gtaggcgtgt acggtgggag gtctatataa 2700
gcagagctcg tttagtgaac cgtcagatcg cctggagacg ccatccacgc tgttttgacc 2760
tccatagaag acaccgactc tactagagga tcgctagcgc taccggactc agatctcgaa 2820
tttctagaaa tgtacaagga attcgccacc atggcgtcac agaagagacc ctcccagagg 2880
cacggatcca agtacctggc cacagcaagt accatggacc atgccaggca tggcttcctc 2940
ccaaggcaca gagacacggg catccttgac tccatcgggc gcttctttgg cggtgacagg 3000
ggtgcgccca agcggggctc tggcaaggta ccctggctaa agccgggccg gagccctctg 3060
ccctctcatg cccgcagcca gcctgggctg tgcaacatgt acaaggactc acaccacccg 3120
gcaagaactg ctcactacgg ctccctgccc cagaagtcac acggccggac ccaagatgaa 3180
aaccccgtag tccacttctt caagaacatt gtgacgcctc gcacaccacc cccgtcgcag 3240
ggaaagggga gaggactgtc cctgagcaga tttagctggg gggccgaagg ccagagacca 3300
ggatttggct acggaggcag agcgtccgac tataaatcgg ctcacaaggg attcaaggga 3360
gtcgatgccc agggcacgct ttccaaaatt tttaagctgg gaggaagaga tagtcgctct 3420
ggatcaccca tggctagacg ctgactcgag ttcgaacccg ggcccggatc cctagataat 3480
tctaccgggt aggggaggcg cttttcccaa ggcagtctgg agcatgcgct ttagcagccc 3540
cgctgggcac ttggcgctac acaagtggcc tctggcctcg cacacattcc acatccaccg 3600
gtaggcgcca accggctccg ttctttggtg gccccttcgc gccaccttct actcctcccc 3660
tagtcaggaa gttccccccc gccccgcagc tcgcgtcgtg caggacgtga caaatggaag 3720
tagcacgtct cactagtctc gtgcagatgg acagcaccgc tgagcaatgg aagcgggtag 3780
gcctttgggg cagcggccaa tagcagcttt gctccttcgc tttctgggct cagaggctgg 3840
gaaggggtgg gtccgggggc gggctcaggg gcgggctcag gggcggggcg ggcgcccgaa 3900
ggtcctccgg aggcccggca ttctgcacgc ttcgaagcgc acgtctgccg cgctgttctc 3960
ctcttcctca tctccgggcc tttcgacctg cagcccaagc ttaccgccac catggtgagc 4020
aagggcgagg agctgttcac cggggtggtg cccatcctgg tcgagctgga cggcgacgta 4080
aacggccaca agttcagcgt gtccggcgag ggcgagggcg atgccaccta cggcaagctg 4140
accctgaagt tcatctgcac caccggcaag ctgcccgtgc cctggcccac cctcgtgacc 4200
accctgacct acggcgtgca gtgcttcagc cgctaccccg accacatgaa gcagcacgac 4260
ttcttcaagt ccgccatgcc cgaaggctac gtccaggagc gcaccatctt cttcaaggac 4320
gacggcaact acaagacccg cgccgaggtg aagttcgagg gcgacaccct ggtgaaccgc 4380
atcgagctga agggcatcga cttcaaggag gacggcaaca tcctggggca caagctggag 4440
tacaactaca acagccacaa cgtctatatc atggccgaca agcagaagaa cggcatcaag 4500
gtgaacttca agatccgcca caacatcgag gacggcagcg tgcagctcgc cgaccactac 4560
cagcagaaca cccccatcgg cgacggcccc gtgctgctgc ccgacaacca ctacctgagc 4620
acccagtccg ccctgagcaa agaccccaac gagaagcgcg atcacatggt cctgctggag 4680
ttcgtgaccg ccgccgggat cactctcggc atggacgagc tgtacaagga atttggcagc 4740
ggccagtgca ccaactatgc cctgctgaaa ctggctggcg atgtggaaag caaccccgga 4800
cccatgaccg agtacaagcc cacggtgcgc ctcgccaccc gcgacgacgt ccccagggcc 4860
gtacgcaccc tcgccgccgc gttcgccgac taccccgcca cgcgccacac cgtcgatccg 4920
gaccgccaca tcgagcgggt caccgagctg caagaactct tcctcacgcg cgtcgggctc 4980
gacatcggca aggtgtgggt cgcggacgac ggcgccgcgg tggcggtctg gaccacgccg 5040
gagagcgtcg aagcgggggc ggtgttcgcc gagatcggcc cgcgcatggc cgagttgagc 5100
ggttcccggc tggccgcgca gcaacagatg gaaggcctcc tggcgccgca ccggcccaag 5160
gagcccgcgt ggttcctggc caccgtcggc gtctcgcccg accaccaggg caagggtctg 5220
ggcagcgccg tcgtgctccc cggagtggag gcggccgagc gcgccggggt gcccgccttc 5280
ctggagacct ccgcgccccg caacctcccc ttctacgagc ggctcggctt caccgtcacc 5340
gccgacgtcg aggtgcccga aggaccgcgc acctggtgca tgacccgcaa gcccggtgcc 5400
tgaccgcgtc tggaacaatc aacctctgga ttacaaaatt tgtgaaagat tgactggtat 5460
tcttaactat gttgctcctt ttacgctatg tggatacgct gctttaatgc ctttgtatca 5520
tgctattgct tcccgtatgg ctttcatttt ctcctccttg tataaatcct ggttgctgtc 5580
tctttatgag gagttgtggc ccgttgtcag gcaacgtggc gtggtgtgca ctgtgtttgc 5640
tgacgcaacc cccactggtt ggggcattgc caccacctgt cagctccttt ccgggacttt 5700
cgctttcccc ctccctattg ccacggcgga actcatcgcc gcctgccttg cccgctgctg 5760
gacaggggct cggctgttgg gcactgacaa ttccgtggtg ttgtcgggga agctgacgtc 5820
ctttccatgg ctgctcgcct gtgttgccac ctggattctg cgcgggacgt ccttctgcta 5880
cgtcccttcg gccctcaatc cagcggacct tccttcccgc ggcctgctgc cggctctgcg 5940
gcctcttccg cgtcttcgcc ttcgccctca gacgagtcgg atctcccttt gggccgcctc 6000
cccgcctgga attaattctg cagtcgagac ctagaaaaac atggagcaat cacaagtagc 6060
aatacagcag ctaccaatgc tgattgtgcc tggctagaag cacaagagga ggaggaggtg 6120
ggttttccag tcacacctca ggtaccttta agaccaatga cttacaaggc agctgtagat 6180
cttagccact ttttaaaaga aaagagggga ctggaagggc taattcactc ccaacgaaga 6240
caagatatcc ttgatctgtg gatctaccac acacaaggct acttccctga ttagcagaac 6300
tacacaccag ggccaggggt cagatatcca ctgacctttg gatggtgcta caagctagta 6360
ccagttgagc cagataaggt agaagaggcc aataaaggag agaacaccag cttgttacac 6420
cctgtgagcc tgcatgggat ggatgacccg gagagagaag tgttagagtg gaggtttgac 6480
agccgcctag catttcatca cgtggcccga gagctgcatc cggagtactt caagaactgc 6540
tgatatcgag cttgctacaa gggactttcc gctggggact ttccagggag gcgtggcctg 6600
ggcgggactg gggagtggcg agccctcaga tcctgcatat aagcagctgc tttttgcctg 6660
tactgggtct ctctggttag accagatctg agcctgggag ctctctggct aactagggaa 6720
cccactgctt aagcctcaat aaagcttgcc ttgagtgctt caagtagtgt gtgcccgtct 6780
gttgtgtgac tctggtaact agagatccct cagacccttt tagtcagtgt ggaaaatctc 6840
tagcagtagt agttcatgtc atcttattat tcagtattta taacttgcaa agaaatgaat 6900
atcagagagt gagaggcctt gacattgcta gcgttttacc gtcgacctct agctagagct 6960
tggcgtaatc atggtcatag ctgtttcctg tgtgaaattg ttatccgctc acaattccac 7020
acaacatacg agccggaagc ataaagtgta aagcctgggg tgcctaatga gtgagctaac 7080
tcacattaat tgcgttgcgc tcactgcccg ctttccagtc gggaaacctg tcgtgccagc 7140
tgcattaatg aatcggccaa cgcgcgggga gaggcggttt gcgtattggg cgctcttccg 7200
cttcctcgct cactgactcg ctgcgctcgg tcgttcggct gcggcgagcg gtatcagctc 7260
actcaaaggc ggtaatacgg ttatccacag aatcagggga taacgcagga aagaacatgt 7320
gagcaaaagg ccagcaaaag gccaggaacc gtaaaaaggc cgcgttgctg gcgtttttcc 7380
ataggctccg cccccctgac gagcatcaca aaaatcgacg ctcaagtcag aggtggcgaa 7440
acccgacagg actataaaga taccaggcgt ttccccctgg aagctccctc gtgcgctctc 7500
ctgttccgac cctgccgctt accggatacc tgtccgcctt tctcccttcg ggaagcgtgg 7560
cgctttctca tagctcacgc tgtaggtatc tcagttcggt gtaggtcgtt cgctccaagc 7620
tgggctgtgt gcacgaaccc cccgttcagc ccgaccgctg cgccttatcc ggtaactatc 7680
gtcttgagtc caacccggta agacacgact tatcgccact ggcagcagcc actggtaaca 7740
ggattagcag agcgaggtat gtaggcggtg ctacagagtt cttgaagtgg tggcctaact 7800
acggctacac tagaagaaca gtatttggta tctgcgctct gctgaagcca gttaccttcg 7860
gaaaaagagt tggtagctct tgatccggca aacaaaccac cgctggtagc ggtggttttt 7920
ttgtttgcaa gcagcagatt acgcgcagaa aaaaaggatc tcaagaagat cctttgatct 7980
tttctacggg gtctgacgct cagtggaacg aaaactcacg ttaagggatt ttggtcatga 8040
gattatcaaa aaggatcttc acctagatcc ttttaaatta aaaatgaagt tttaaatcaa 8100
tctaaagtat atatgagtaa acttggtctg acagttacca atgcttaatc agtgaggcac 8160
ctatctcagc gatctgtcta tttcgttcat ccatagttgc ctgactcccc gtcgtgtaga 8220
taactacgat acgggagggc ttaccatctg gccccagtgc tgcaatgata ccgcgagacc 8280
cacgctcacc ggctccagat ttatcagcaa taaaccagcc agccggaagg gccgagcgca 8340
gaagtggtcc tgcaacttta tccgcctcca tccagtctat taattgttgc cgggaagcta 8400
gagtaagtag ttcgccagtt aatagtttgc gcaacgttgt tgccattgct acaggcatcg 8460
tggtgtcacg ctcgtcgttt ggtatggctt cattcagctc cggttcccaa cgatcaaggc 8520
gagttacatg atcccccatg ttgtgcaaaa aagcggttag ctccttcggt cctccgatcg 8580
ttgtcagaag taagttggcc gcagtgttat cactcatggt tatggcagca ctgcataatt 8640
ctcttactgt catgccatcc gtaagatgct tttctgtgac tggtgagtac tcaaccaagt 8700
cattctgaga atagtgtatg cggcgaccga gttgctcttg cccggcgtca atacgggata 8760
ataccgcgcc acatagcaga actttaaaag tgctcatcat tggaaaacgt tcttcggggc 8820
gaaaactctc aaggatctta ccgctgttga gatccagttc gatgtaaccc actcgtgcac 8880
ccaactgatc ttcagcatct tttactttca ccagcgtttc tgggtgagca aaaacaggaa 8940
ggcaaaatgc cgcaaaaaag ggaataaggg cgacacggaa atgttgaata ctcatactct 9000
tcctttttca atattattga agcatttatc agggttattg tctcatgagc ggatacatat 9060
ttgaatgtat ttagaaaaat aaacaaatag gggttccgcg cacatttccc cgaaaagtgc 9120
cacctgacgt cgacggatcg ggagatcaac ttgtttattg cagcttataa tggttacaaa 9180
taaagcaata gcatcacaaa tttcacaaat aaagcatttt tttcactgca ttctagttgt 9240
ggtttgtcca aactcatcaa tgtatcttat catgtctgga tcaactggat aactcaagct 9300
aaccaaaatc atcccaaact tcccacccca taccctatta ccactgccaa ttacctgtgg 9360
tttcatttac tctaaacctg tgattcctct gaattatttt cattttaaag aaattgtatt 9420
tgttaaatat gtactacaaa cttagtagtt tttaaagaaa ttgtatttgt taaatatgta 9480
ctacaaactt agtagt 9496
<210>3
<211>22392
<212>DNA
<213> Unknown (Unknown)
<400>3
gtacagtgaa gtatacaact ttgtgcaggg caatttatca atatttattg aaattaccaa 60
aaaacatgct ctctgaacaa actattctac cagtgtagaa agcagagtaa acttcatggg 120
tgagtgacca gggcagtcac acaagggccc catgcttaga agggatactg tgtttgggtt 180
ctaaagctct gtggttcctg tcttgaaatt cttaataatt ttatctttca atttgtgtct 240
tataatgaag tccgatgaga aagcagaaca tgggctagag acttttggag cctggctcaa 300
gcgaggtcct gctccccatg cctcccagcc tccccaggac tggttttcag ctgccggctc 360
caccaccttc tgtgcaggct cgctcccagc aggggcctgg gaacagtgga aaggagggga 420
gcggtcaggc atacacacct cccttgccaa atggaaggca tggccctagg cacttgtgaa 480
gatctgcact tccccctagg tactcctgtg cctggagtgt gacattaaat taaaaaaaaa 540
aaggccgggc gcggtggctc acgcctgtaa tcccaccatt atgggaggcc aaggcaggcg 600
gatcacgagg tcaggcgatc gagaccatcc tggctaacac ggtgaaaccc cgtctccact 660
aaaaatacaa aaaaattatc tgggcatggt ggcgagcgcc tgtagtccca gctacttggg 720
aggctgagac aggagaatgg cttgaacccg ggaggcggag gttgcagtga accgagattg 780
cgccactgca ctccagcctg ggcgacagag cgagactcca tctcaaaaaa aaaaaaaaaa 840
aagaaaagaa aaaaacccca cataataggt tgacagtgga accacagaaa aaaggaaaag 900
gttgggtttt ttttctgctt tttattttct attttattat tttttaatag atttatttaa 960
ctagagatgg ggtctcacta tgttgtaaag gctggactcg agaccctggg cccgagcgat 1020
cctccaacct ggtcctccca aagtgatggg attacaggcg tgagccactg cacctggtct 1080
tttcctgcta ttaaacaagg agctccatag tttcattttg cccctcaaaa tatgtagctg 1140
gccttagtag actgatattc attgccaaat tatatgtaag agcaaaaagg ttgaaaatga 1200
tggcctgaca ttgatcaatt tgtgccttta ggtaacatat aactgtaata taactgcaat 1260
acaactagaa tataactcat aaaggcaaga atcttgtctg ccttgctgaa agttttataa 1320
tcagggccta atataaagta tgacacatag cacttgcttt taaatatgta ttgatttaaa 1380
ttaattgagt acatttttgc ttcatcctag taaaaatagg tatttaaaaa actgaaacag 1440
tctaaatgtc ttgggatgct acttaaataa ctatattata ttcatccaat aaaatattgt 1500
aagctgttta aaaataacaa ggatgttctt taggtactga taaggaaaga gcttcaagat 1560
aaattgttac catttatgta aaacaggtgg gagaagggag agggagggat gtgtgagcgc 1620
tacttgcagt actcacaggc agtgactttc gtggagcgcc ctctagtggt atatatatac 1680
aaacggaagg atttagagaa aatacagatc ggctttagct ggctgagatt tattttcaaa 1740
gcatgttact ttataagaat caatttttat ttaaaaaatt tttttgagat agggtctcac 1800
tctgtcgcac aggttggagt gcagcagcac gatcagtgct cactgcagcc tctctctctt 1860
gggctcaaca ggtgcatgtc accacgtcca gctaacaatc aattttcaaa agtacaaaaa 1920
agccatatta tgtattaatg tggaattatg aattaagtag acaacaagaa tcaaaacagg 1980
gtgtctatta tcacttctga taacataaat aatgtaaaga tacatatttt acagattatc 2040
tgtaaaagct tatacagtac tgttgctggg tatttatgta ggaaagctac catttattga 2100
atgcttacta tttcacatat ggacagcata gagcatgtta aaaaattacc acacacattt 2160
actgtattca atgtgtcact ctgaatatat tactgtgtac atggtctgtc attggacatg 2220
gtgagagatg cagattaagc tgaaattact gaggacagca acactggaag aaaattgagc 2280
tgggtgtagt ggctcagcct gtaattccaa catttcagaa ggctgaggca ggaggatcac 2340
ttgagtccag gagtttgaga ccaagggaaa gaaaagaaaa gaagctttca tttagccagg 2400
catgctggca catacctgta gtttcagcta ctcaggaggt tgaggcataa ggttcactta 2460
aacttgagag gtaaaggctg cagtgagccc tgatcacgcc actgctctcc agcctgtgac 2520
agagagagac cctgtctcaa aaacgagaaa gaaagaaaaa aagaggcaac tcaagaactc 2580
aggaatactt gcaggatctc ataacatatg ctatacaaaa tcaattaaaa taatatttaa 2640
atgctgaaag aaatgagcag ctcccagggt gatacagggt ggtttcactt cttggacaca 2700
tctacactga gctctattcc tggcaatacc tgatgttccc ataccccaga tttctttatt 2760
ttattttgag acggagtttt gctcttcttg cccaggctgg agtgcaatgg cgggatcttg 2820
gctcaccgca atctccgcct cctgggttca agggattacc ctgcctcagc ctcccgagta 2880
gctgggatta caggcgcacg ccaccatgcc cagctaattt ttgtattttt agtagaggca 2940
gggtttctcc atgttggtca ggctggtctt gaactcccaa cctcaggtaa tctgcccgct 3000
tcggcctccc aaagtgctgg gattacaggc gtgagcgggc ccagccccta taccccagat 3060
ttctgcaagt ggcaacacca ctggcttcat tttgctggtg gcccctctgg ccttcccttg 3120
tatatatcac ctttgcccaa agaccatgtc agccaaggga ctgctctcac agctccagga 3180
atcctcccct ttcaggaaat ttgaggcagt tgagggcatg aaagtaaata agctgagctc 3240
atcagaggcc ttgtattgtg gtggttaaaa gagccagttc taggactaga aagcctggct 3300
tgaaatccca gctctgccac tccctagtgg tgtgacttta gcaagttcct ttacctcttt 3360
tgtacctccc ttttctcacc tgtaagatat gggtgataat agtttaatat ttgttttgtt 3420
gttgtgagga ttaaaggtgt taatgcaagt aaaccactta gaaccacagc acatagaata 3480
tctcagtaag gtggttagtt ttttttattg ttgttttcag agatgctgtg atttctccaa 3540
agtggctgtg atggctcggc aggctcctga ccctctctgc tcccacatgc ctccaccctc 3600
atcctgatct cccatccagc ttttgacagc ttgcttggtg ctggacaatt gcacacatct 3660
taccaccccc aaatcctgcc cagaagcatc ttgtgcataa ctctcctacc tgaatatgca 3720
acagggagaa agagcgtccc aggacatttt aggtttttga agaaaaaaaa acccctttgg 3780
taaaaagcca gagatccaca gcggccactt tttccatggg attgacccct gcaatcttga 3840
ctttcaacca cacagcacca gagtagccaa acattgcttg tgtccaaacg ctggctgcct 3900
tgaagggtga aagaataagc agttcccaaa ctcagctgac cttaatgtcc ttctagctcc 3960
ttacgcccat ctcggacaaa agcagaaatg tatgtctcag ttgtgtttct accccttgct 4020
gcccaatata aatttttgtg ttgcccaata taattttttg tgacgatgga aatgttctgt 4080
atttgtgttg tctgatgaga taaccactaa ctgtagtgct attgagcatt tgaaacatgg 4140
ctagtgtaat caatgaacca aatttttaat tttatttaat tgtaattaat tttaagtggc 4200
cacatgcagg gagtgactgc tgcattggac agcacggctc taaattgagc cttttttcct 4260
tatttggtga ggcatacttg ccttaagatt gggaagtcta tttttggaac ctgctaccaa 4320
tgctggtctc acacttgcaa ttctcagctg agccaagagg tgagagaaag gtcattttcc 4380
attccagatc tcactctccc ctgtgacact gaggaaactg gcaagtgatg tgaaggctgg 4440
agagcgtgtc ctgtatgctg gctctgtccc ttctgcctgt gttgactgac atagttagtt 4500
gctgcccttg ctggtctccc ttcctccaac cttgcctctc tgagcacacc tgacattcat 4560
ctcatgactt ccctaaaaac attctttggg aacaagaaac taacaaatcc caagtgacct 4620
atcacatata caaacataca gggcagagtt tggattcgcg gtagaagaaa gggaggttag 4680
acattaagaa gaatggtctg gtgatgacag ttgtgagata atagaaacag gaaaaagaaa 4740
tctaagtttt ctttcttttt ttaagaacca ataataattt ctctcttttg actagtcagt 4800
agggctgggg tggattggag gaagcttaca tattccatga acaagcctct tcctaaggtc 4860
ctgtaagtga tcctgcccca ctgattagcc cctagaagac ccttcaaagg ttggatctcc 4920
aggagggagt gggggaggaa agccctgtac caggcagcct ctgctccatt gctctggggg 4980
ggtggggaag gcaaaccctg gtcatcccct cagtctgtag cccttttgtg tgagtgcctg 5040
gcaagggtga cgtggggctg tttctgcggg cacagctgca gcaattaccg gagtggaggc 5100
agggcccagg cagcactgcc ctccaagatc ttcccttggg cttttcagca gtaaggggac 5160
atgcacccca agggcctcca cttggcctga ccttgctgcg ggggctctct gtccccagga 5220
acagtagaga tggcaagctt atcaagaccc tctctgccca gctgcctctg ctccttcctc 5280
ctcctcctcc tcctccaagt gtcttccagc tatgcaggta agacatgttt tttttcctgc 5340
cctggggaga ccctgaaaac agaaaggcta gtttcctggg gcttagctcc ttcaaacatc 5400
ctcaagttgc tatattatct ttctaaaaca tagacctact gacatgcctc ccttcctcag 5460
aaaccttccg tgggtggttc ttacagcctt caagatggag tccagactct tttttttttt 5520
tgagacagag tctccctctg ttgctcaggc tggagtgcag tggcatgatc tcggctcact 5580
gcaacctcag cctccctggt tcaagcgatt ctcctgactt ggcctcccaa gtagcggaga 5640
ctacaggcgc ctgccaccac acccagctaa attttttctt ttcttttttt tttttttttt 5700
ttttgtattt tagtacagac ggggtttcac atgttggcca ggatggtctc gatctcttga 5760
cctgctgatc cgcccgcctc agcttcccaa agtactggga ttatgggcgt gagccactgc 5820
actaggccta atttttttat ttttagtaga gatggggttt caccatgttg gccaggctgg 5880
tctggaaccc ctgacctcaa gtggtctgcc ctcctcagcc tcccaaagtg ctgagattac 5940
aggcatgagc cattgcgtct gacccagact ccttaatgtg actaactcaa ggctttcctt 6000
gaactacttc ttacttgtct ttccagcttt gtcttttcac ctctcaaatt gagataaaat 6060
aataacaacc tcttggagtt ctcatcagga ttacatgaaa tgagatatgt aacatgctta 6120
gcagtgcctg tccatagtaa atctcaataa atgtttgtgg aattataata tcttgtcatg 6180
tttgagactt tgctctgcat aatcaggcac cagtaggttt ttataaagga acccggctgt 6240
cacgtgcaga ggagaaataa acagaaagtt tcccatcctc agggagccac ctgactgaca 6300
gaggcacagt gcatccactc tccaggtcta ggggagaaag cagccttatt tcttagtagc 6360
tcagaatctg acttgagaaa cacatccaca tagaaaaaaa caaggaactt tttcgggtca 6420
gggtccggga gccacagtga ggtggaagat acaggggaag gaagagggaa atagagccat 6480
ccccagggtg gaagatctca gaagagaatt tgggaaacaa ggtatgaaca aggactgaat 6540
agtgagaagt gatggagaga cagttaaagt agatggagtg acaaaagcaa aacctctaag 6600
ggtagaatag gcagcaattt ggccaagtcc taacagggag gcccatagga ggattcaacc 6660
tcaagatgct gtgccacatt ccaagaggga acctaaaggc tgggctgaag agtcagagat 6720
ggctacagct ggcaaaaaga tgggcagatg ctgagaggag atgattgcta aaatgttctg 6780
tccaggacat tcacagtatc tctataacca gagtcttttt tgtcgttgtt gttctcaaga 6840
aggaaacttg aggccgggtg tggtggttta tgcccataat cccagcgctt tggggccaag 6900
gcaggcggat cacctgaggt caggagttcg agaccagcct ggccaacagt gtgaaacctc 6960
atctttacta aaaatacaaa aattagctgg atgcggcggt aggtgcctgt aatgccagct 7020
actcgggagg ctgaggcagg agaatcactt gaacctggga ggcggaggtt gcagggaggc 7080
ggaggttgca gtgagccaag attgcaccac tgcactccag cctgggcgac agagagtaag 7140
actgtctcaa aaaataaatg aataaataaa aaggaagaag aagaagaaga acaattgcaa 7200
tcctccctgg ctctagaatg tcatttaaaa gtcgagtgtc ttcttccttc cctgttttga 7260
agcagccctt ctcatgacag gcttgcttgc caaggttccc tctgacctta aatctcttcc 7320
ttttggtgtc ttggacaggg cagttcagag tgataggacc aagacaccct atccgggctc 7380
tggtcgggga tgaagtggaa ttgccatgtc gcatatctcc tgggaagaac gctacaggca 7440
tggaggtggg gtggtaccgc ccccccttct ctagggtggt tcatctctac agaaatggca 7500
aggaccaaga tggagaccag gcacctgaat atcggggccg gacagagctg ctgaaagatg 7560
ctattggtga gggaaaggtg actctcagga tccggaatgt aaggttctca gatgaaggag 7620
gtttcacctg cttcttccga gatcattctt accaagagga ggcagcaatg gaattgaaag 7680
tagaaggtga gtagtgccat ataatattag gtattaactg ttgggtggcc aagaacaatt 7740
attctctcaa ctgagatgag atccctcaac ccaaacatct cagtcctggg aatgatttcc 7800
ataaaaatgt acacatcaat aaacagaaac tcatgcttag ggatgtctgt tgcatcatta 7860
ttcagagtag caaggaaatt gggatcaaaa tcaatgcctt tgagtaggta agtgacagaa 7920
tgaacaatgg tagccatact gtgaatatta tgcaggcatt aaaaagatta ttttagcact 7980
aggccagatg gtttggaggc cttctataag gtattattga gtgataagag caagctgctg 8040
taggatacaa aaacaaaaac aaaaccctag ggcatggtgg tttgcctcgc agctactcag 8100
gaggctgaga cgggaggctg gcttgagccc aggggtttgc agttacagtg agctatgatt 8160
gcaccactgc actccaaccc gggtgacaga gcaaagacct tcacccccac tccctacccg 8220
tctctaaaaa aaacaaaaac aaaaacaaaa aaacccttgg gcccagcgcc gtggctcacg 8280
cctgtaatcc cagcactgtg ggaggccgag gtgggcagat cacaaggtca ggagatcgag 8340
accatcctgg ctaaaacggt gaaaccccgt ctctactaaa aatacaaaaa aaaaaaaaaa 8400
attagccagg catggtagca ggcgcctgta gtcccagcta ctcgggaggc tgaggcagga 8460
gaatggcgtg aacccggaag cggaggttgc agtgagccaa aatccttcca ctgcactcca 8520
gcatggggga cacagcgaga ctccgtctca aaaaaaaaaa aaaaaccctg tatttgtgag 8580
cgcacacaca cacacacaca cacacacacc tgtgcttggt cctagtgaat aagcaagtaa 8640
atcaaatgtc taaatataat tatagaaagg agatgtcact ttttggctgt acctccacta 8700
tttcattctg cagaattgca gaatttcttt ttttttttcc tttctttctt ttcttttttt 8760
ttttgacaca gagtctcgct ctgtcaccca ggctggagtg caatggcgcc ctccgcctcc 8820
tgggttcaag tgattctcct gcctcagcct cccgagtagc tgagattaca ggtgcccacc 8880
accacaccca gctaattttt gtatttttag tagagacagg gtttcaccag gttgtcaagg 8940
ttggtctcaa actcctgacc tcaggtgatc cactcgcctc agcctcccaa agtgctggga 9000
ttacaggcat gagccatggt gcccggcctc agaatttcat tttcaacatg ttttgcatga 9060
tgggtgattt tggagaatat tttttgctct atcgcaggat gattaagatg tggacaaggt 9120
gaagccgatg gagggggagc tttgaaagtt acttgctatt taattgagga actaaactgc 9180
tttgagagcc tgggggtcag atcctctgcc ttttcctcct ccccacctgc agtgcaaaca 9240
tcagacaatt gatcactatt gtatcttgga ggtgggagtg accattgcag tgctgggacc 9300
agaagatggc attgtatgtg gaacaacaaa gcactatttc tagagactgc ctgcagggat 9360
atggaaatag ctttatgtgt ctcagaatgt tcttcataca gctgttttta ttggggaaat 9420
tctacttgcc gaaaagtttg atagtgagac cctctccagt ttgcagattt ttctccttcc 9480
tgctcaacaa cttcctagct cagtaactgc ctctcccaac aaactccctc agtttcacca 9540
caccaaaaaa ggaagacaag ccggttgcgg tggctcacac ctataatccc aaaactttgg 9600
gaggccgagg cgggtggatc acctgaggtc gggagttcga gactagcctg accaacatgg 9660
agaaaccctg tctctactaa aaacacaaaa ttagcctggc gtggtggcgc attcctgtaa 9720
tcccagctgg gaggctgagg caggagaatc gcttgaaccc cggaggcgga ggttgcagtg 9780
agccaagatc gtgccattac actccagtct gggcaagaaa agtggaactc catctcaaaa 9840
aaaaaaaaaa aaaaaaaaca aggaagacaa aaagaaaagc agctaaagac tttgcctcag 9900
gggagaaagt tctcttttgg gttgctatcc acattccaac ctcctgttcc cacctcttcg 9960
tctgcatgcc taagaaactg ttttacaagt aaataaggga cgctttgtct aggctttgga 10020
gccaggaagt tgagacaaat ttaggaatga gatgaagtaa tggtattatt gcaagtctca 10080
ggtgtaacta cctctgctct ttctctgaag agtttctaat ttctcttgtt tacttatttt 10140
tttcttgtca tttttgtgat tttattacta gttgtctcta atcctttctt taaattcttc 10200
attatgaaac ataaaaacaa atgccaggcg cggcagctca cgcctgtaat cccagcactt 10260
tgggaggccg aagcgggcag atcacccgag gtcaggagtt cgagaccagc ctgatcaaca 10320
tggagaaacc ccgtctctac taaaaaatac aaaattagct aggcgtggtg gcacatgcca 10380
gtaatcccag ctacttgaga gactgaggca ggagaatcgc ttgaaccggg aggcagaggt 10440
tgcggtgagc caagatcgcg ccattgcact ccagcctggg caacaagagc aaaactctgt 10500
ctcaaaaaaa aaaaaccaca tacaaaccag agataatatt ataatgagcc tccaagtgcc 10560
taccaccttg ctgcagcact tgtcaatcca gggaccaccc acctcaccgg ctccccactc 10620
attaccaccc tcccctactc aattactgag gtaaatccta ggcagcatga tcatttcttt 10680
tttttctttt tatttatttt gagacaggat ctgtctctgt cacccaggct ggagtgtagt 10740
ggcatatctc tgctcactgc agcctctgcc tcccgggcag aagccatcct cccacctcag 10800
cctacatagt agctgggacc acaggcacac accaccacac actgctaatg ttttgtattt 10860
tttgtagaga ctgggtttta ccatgttgat caggctggtc tcaaactcct aggctcaagc 10920
aatcctccca cctcggcctc ccaaagtgct agaattacag gcgcgagcca ctgcacccag 10980
cgaagaacac tttttaaaaa ataaataggc cgggcgcggt ggctcacacc tgtaatccca 11040
gtactttggg agcccaagga gggcgaatca tgaggtcaag agattgagac catcctagct 11100
aacatggtga aaccccattt ctactacaaa tacaaaaaca aaattagcct ggcgtggtgg 11160
caggcgcctg tagtcccagc tacttgggag ctgaggcagg agaatggagt gaacccggga 11220
ggcggagctt gcagtgagct gagatcatgc cactgcactc cagcctgggg caacagagtg 11280
agactcaaaa aaaaaaaaaa aaaagccccc cctccccaca cacaataata taaataaata 11340
aataaccaca atactattat cacatcttac aaactcaaca aaaatttctt aatatcatca 11400
aatacccagt ttgtgttcaa attttcctga ttgtttcata aatatactct tacagttggt 11460
ttcttttagc gagattcaaa tgagacccac ctgttgacct ttgcccttag ggtttcccag 11520
ggtctgaatt ttgttgacga cattcccatg ttgctatgta atacggtcct ccatgccctg 11580
tgtttttctg taaactgata gatgtggagg tgcaatgaca tttgtgtttg atttactttg 11640
gcaaatatag ttcatcagtg atactctata cttcttgttg ctttacatcc ggaggctgat 11700
aatgtctgct tttctctctt ttctaattat ttgtgaaagg aaaaatgtgg ggggttggga 11760
gaaaaaaacc cttaagtaca tactcgctaa atcacattgc tacaggtaac ttccattaag 11820
aacttgaaag taaaggtagc tgcattttcc cctagggaac acaatgatag acaggagcct 11880
tagtctacag cttgaaggat tgtaattata cctaagcaac cctcctggac cagtttaatg 11940
ttattagctg tgatgtatcc ctacctttga tgtcattatc cttactcagc tcccttaaag 12000
cagagatcaa gatgaaaagg gcttcagctg cagcatggca catggagatt agagtggggc 12060
ttttggatgc tgaggagcag acctagaatg ggaaatagat gggagccaca gaagtgaagg 12120
tccccctccc tcattgctca acctactcca catctccagg tctgcacatc tgttcagtta 12180
ctgaatcctg tgtaagctac cttctttttc ttttttcttt tatttattta tttatttttt 12240
ttttgagatg gagttttgct cttgttaccc aggctggagt gcaatggtgc aatctcggct 12300
cactgcaccc tccaactccc aggttcatgc aattctcctc cctcagcctt ccaagtagct 12360
gggattacag gctgcaccac catgtctggc taatttttgt attatcagta gagagagggt 12420
ttcaccatgt tggccaagcc ggtctcgaac tcctgacctc aagtgatcca cccaccttgg 12480
cctcccaaaa tgctgggatt acaggtgtga gccaccatgc ccgctgtaaa ctaccttctt 12540
aaaagctcta gaagagggct cttaaccttt tgttgtgtgt catgcacctt ccgcaagctg 12600
atgaagttga tagacccatc tcagaatttt tttttttttt ttgagacagt gtctcactct 12660
gtcacccagg attggttgca gtggcacgat catggctcat tgcagcctcc acctcccagg 12720
ctcaagtgat cctcctgact cagcctcttg aatagctgag accacaggct tgtgtcacca 12780
tgcccaggta atttttaatt ttttttcgta gaggcagggt ctcacattat gttgcccagt 12840
ctggcctcga gaactcctgg gctcaagcaa tcttcctgcc ttggcctccc aaagtggtgg 12900
gattacaggg gagagccacc acacctagcc agaagaatgt tttaaataca ccaaataaaa 12960
catttatacc aaaatacagt tatcaaaata ttaaattaac aagagttagg gtgaccctat 13020
taattagtgt aatttcaaaa tagtaatgaa cataagtgat agtttgagat ttctgtgact 13080
tttctaatgt gacgtgaaaa tatttgtgat ttttcttttt cttttttttt tttgagatgg 13140
agtttcgctc ttgttgccca ggctggagtg caatggcaag atctcggctc acctcaacct 13200
ccgcctcctg ggttcaagcg attctcctgc ctcagcctct tgagtagctg ggattacagg 13260
actgtgccac cacgtccagc taattttgta tttttagtag aaacagggtt tctccatgtt 13320
ggtcaggctg gtcttgaact cccaacctca ggcgatccgc ccgcctcggc ctcccaaagt 13380
gctgggatta caggtgtgag ccaccgcacc tggccaatat ttgtgatttt tattgacgac 13440
aaagtcaaag gttctcttca tattattgtg gtgtatcgcc tacaagcata attaaaataa 13500
acactaaatt tcagtttaaa gtttactgaa aataaatatg tattttttat tccctattta 13560
agctttgaat cccctgactt cctataccat taccactgtc ctagttcagg ttcatgttgt 13620
tttttacttt aattgttatc acagtctctt aacatttctc cctatgttct ccagtcctgt 13680
aggtgctaaa tctgacgtgg tcacttctca gcttggaatc cttcagtgca ccaccacagc 13740
cttgaactac atatttgaaa tacatattta ttttcagtaa actttaaact gaaatttagt 13800
gtttatttta attatgcttg taggcgatac accacaataa tatgaagaga acctttgact 13860
ttgtcgtcaa taaaaagtcc cttgagggac ttcagatgta agtcccttag ctgctcgtta 13920
aaactccccc agcctgaccc aatacacaat cttgacttta aaccacttgt cattctaaat 13980
cactagcatt tcctggaaaa aaaagccatt tttccttcag ggctaagctc agggaccaat 14040
tctgtgtcac cttctttgaa tcctgatgat attcacttct ttatttgacc tgatttattg 14100
ggccccagac accatgctga gtgttgggga ttcagctctg gacaatgtca aatgtcagtc 14160
ctgcctttca gatcctttct actgggtgag ccctggagtg ctggttctcc tcgcggtgct 14220
gcctgtgctc ctcctgcaga tcactgttgg cctcatcttc ctctgcctgc agtacagact 14280
gagaggtaca gggcagaggg tgggtggatc aggatccttt ctttaaatga gctggcttct 14340
tggagctaca ccacttaaca tgtatttgtg agtgacttct gggttcagaa gttcttctca 14400
ctattgagtg ataaagaaaa aaaataactc catgatgaaa gagttttaca tcttacggaa 14460
tgctttcata tgaataatcg gacctagcat ttccctatga gctaactatg ccatatagta 14520
accccatttt acagaggata caactgaggc caggagtagt tcagtgactt actcaaaccg 14580
atataactta taagtggtag agctgaggcc tctgtatcat acctagcagc tccatgcaac 14640
ttgggagagt gtgagcttcg aagtcagaca ggtctaggct attaggagtt ttgaataaag 14700
atactgaagt gaaagtctct accacacagt aggcgttcga aaattgtttc ctctttctcc 14760
attcaacact gaggactcag gttcagctgc tgatgaagct cctctttttt gcctagagct 14820
ttcattctga gccttctcct cctaccaagt gtctccccaa tgccagagca ggaagagtct 14880
tcactcctcc ccatgcccca cctcccattt gttactaaga ggagaggaga aagtagcaag 14940
gagggtatgg ggaatgttct gggggaatgg gtgttggtgc gatcaacaac aaagtccttt 15000
ctctcacctt gaattcatcc cagatgcctg cttgtttact tcttccacac aaaaaaaggc 15060
cttcagccct catggctgag cagaaagaat ctgaatgtta gagtcaggca gcctgggttt 15120
gaattccatc tcaggtactg aactctatag caaaattctt agattctcca agcttcagtt 15180
gccttgtctg tcaaatagag aaaacatcct tcgtcctaaa ttgtagggag gattaaagtc 15240
atgcaaagtg cctactacaa atccagtcac aaagtagcta gctactcact aaatgttcag 15300
ctcctccctc ctcattcaga tgggaagtgg ctttagataa acaaagtggc aacgcagtgg 15360
gctggagcag ctctgtgaac tgagaatcca agaaaagggg cgaagagcag ctgggatgta 15420
ttggatgctt gtgctggctt ggagcattgc tcacattctt tattcgctat tgtatctaga 15480
ctatagctag agaaagagcc gcaaccattg gctttaaatc cagtgctctt cctactctcc 15540
tgaggttgtt tccaggctgc agagaaatag cctgcacaag gggcccaggc gctgggtgtg 15600
ggagggtccc caccgagagc cagaacatgc aggaactaaa atgttgcctt tttctatttt 15660
aggaaaactt cgagcagaga taggtgagtt ccagtcatcg tttctcccaa ttcttgcctt 15720
ttggtttttt ggcataacgg aaatggtccc gttcttggac cgtctctccc tctcaatacc 15780
ctgttttccc ctcagtttcc ctttctctac agtgggtgtg tcgtgcctag aacaagtttt 15840
aagtaattaa ataacaaaga ctcaggataa aagatccttt ttgagtgccc tactaaatcc 15900
atttccattt gtttctcttt cagagaatct ccaccggact tttggtaagt tccggcatgt 15960
ctaggccctc ccaggtcaac ttggtatttc actctagttc cagtcacctg ggggaacaag 16020
gacccctggc tcctggttga gtcccttcct ctcttctctt ttctttcttt aaataagaag 16080
tcatttgcat ttaggattgg taaaatcata ataaaaatac tcatgtactg tttttatgtg 16140
ccaggcacta ttctaactac tttacaaaaa tgttatctta ttctgtttaa ctccttatgc 16200
acatgatctc tcttttcagg aatggcaaaa cagaggtaaa tagatcgttt acacgtaaac 16260
ctgatgtctg gttggggagg tgaaacaaac agaaacaaga cacaactgta tcacctgtac 16320
ttatatttct gctttacaaa ctcaggatgt ttccatgagt acagaacatg actaatcaga 16380
gaagacctca tagaggaata gaaaagccac caagccccac taggaattga cccctcaagg 16440
acatggtttc tagccttttt gttcactgca gattgcccaa tgcctaaaga taatggcaac 16500
agaagagcac ccaaatattt gttagataaa tgttgcagac actagaaggt gtcattaggg 16560
cacagatggt accttctctg agcaaacttc cttcacagct cctcctcccg aggctgtagg 16620
tgactctact cttgtcacct ggcacacaga gttctatcgt acgatttagg aaattagacc 16680
agtgtgtgga ccacacacac acacatcttt acacacccaa agaggaggaa tagtatcttt 16740
gttttggagg acttgactat gaaaggtctt aactcctttt tgtaccatga atctctctgg 16800
cactccagtg aagtctaaag gacccctttg cagaatgttt ttaaatatac acataaaata 16860
gaacacatag gattgcaaaa acaatcattg tactaaaata cagttatcaa ccgataatca 16920
catttgtgat atagtaacat aaatgtttct tttttttttt ttttgaggca gagttttgct 16980
cttgtcaccc aggctggagt gcaatggcgc gatctaggct cactgaaacc tctgcctccc 17040
gggttcaagc gattctcagc ctcctgagta gctgggatta caggtgcccg ccaccacacc 17100
cagctaattt ttgtattttt agtagagact aggtttcacc aggttggcca ggctggcctc 17160
gaactcctga cctcaggtga tccacctgcc ttggcctccc aaagtgctgg gattacgggc 17220
atgagccacc gtgcccggcc ataaatattt ctttagccaa agtaatacat taagtaatgt 17280
agcagcaagt ctaataacct gtaatttctt tctttctttc tttctttctt tttttttgag 17340
atgaagtttt tttgagatgg agtgcaatgg cacaatctcg gctcactgca acctccacct 17400
cctgggttca agcgattctc ctgcctcagc ctcccaagtt gctggaacta caggcgcatg 17460
ccaccatgcc cagctaattt ttgtattttt agtagagacg gggtttcacc atgttggcca 17520
ggctggtctt gaacccctga cctcaggtga tctgcctgcc ttggccttcc aaagtgctgg 17580
gattacaggc atgagccacc aggcccagcc caataacctt taatttcaac atactaataa 17640
acataaacag tatttcaaga tttctgcaat aactctaatg ggaatgaaaa catctgtggc 17700
ttccattggt aattaagtca caggtactgc tcatattgtg gttagttgta aaatgttttg 17760
gtttgttttg ttttttccaa gacttggggg aatgggtgtt ggtgggatca acaagagtct 17820
tgctctgtgg cccaggctgg agtgcagggg caggatcttg gctcactgca acctccgcct 17880
cccaggttca agcgattctc ctgcctcagc ctcctgagta gctggcatta caggcatgtg 17940
ccaccacgcc cacctaattt ttacattttt agtagagatg gggtttcacc atgttggcct 18000
ggctggtctt gaactcttgg cctcatgatc cacccgtctc ggactcccag agtgttggga 18060
ttacaggcat gagccaccac acctggcagt tgttacattt ttaatgaaag aaaatgttaa 18120
atccagttat tgaaaataag gaggcagtac ttttctcatc caagttcatg gactttctga 18180
attttgtccc cagagtcctt tggtgttcta ggaccccagg ttaaggaacc aaaaaagaca 18240
ggtgggtggg gcatgagggg gaacacatgt taaccctgtt tgttctggtg aacaattcag 18300
atccccactt tctgagggtg ccctgctgga agataaccct gtttgtaatt gtgccggttc 18360
ttggaccctt ggttgccttg atcatctgct acaactggct acatcgaaga ctagcaggtg 18420
cagtggctgg gcagcaggca agaccaccaa atagtggggg accaagtcag ctctgaatgg 18480
gaagccaaaa gagaatagaa ccaggactca agattagggg agctgggatt tccttattcc 18540
tctgtcccca tgcccaaccc caggctcttc tgagaaactg tgaagagaac cacttactgg 18600
atctgtggga tcccccagtg gaaagggcag tgtgggtcac tccaaatgtc catagggagg 18660
atgtggggaa ggtgctattc atcttccact aatcacatat ttgtttcttt ttgttttcag 18720
ggcaattcct tgaagagcta cgtaagttct cttctctctg ttataagcag agaataaaaa 18780
gccaggaaag ggagacagaa gcaacaagag gaagaggcgg gctattgagg gatcacattc 18840
ccagaggaaa ggaggagctg gagagcctgg gtggagggaa gactcctcct gggaggtaga 18900
gggcaaagaa gccagctgtt agagacacat ttacaggtgg cagagaagct ggaggcactc 18960
ctatctgcca cctgatccat tcctccttca ctgcccctaa gcaggaatcc aaccctagct 19020
ggtctcattg cccattccac agcaactgcc cagtgcctca cctctcagat caaccattga 19080
ggcaggaatg gagacaagat gaccccaagg gcttttcttc tccctagttc aatggtttta 19140
tgatacaaac tactgacata cgtttttcaa gttattttct ccttcttcta ggaaatccct 19200
tctgagtgat gtcacatctt ggcaggggtg gaggagagcc tggttgccca gggatttgtc 19260
cttggggaca tctcatccat caagttgcac actcactggc atctttgcta tggggacatt 19320
ccaatttgca ctttcaggaa cactctgaat tccaagtaga attgatttcc cttcttctgt 19380
catctacctt ttctcttcat tttcccattt ttattaccct tctttccatt tctctctcca 19440
gtcttccacc tggaagccct ctctggctaa ggacaggcag gtgcccctct ctccatcaga 19500
ggacacctgt actggagagc aacacaggat ggtctctgcc atgaactgga ggccaggaat 19560
ctcctcactg aaaattacag tatggtaact ttgcaaatgg tggttgtttc ttccaagact 19620
ccagccctga ttgcgcaaaa ctgaaaggca tgtgaaggga aggaagagga agagtgcaaa 19680
acattgaaga gagagctgag tgagctgaag agtgaggata tgagtagccc caacccaaac 19740
ctggagatgg ggagaaacct acagaatact agccagagct cctccttgtc ttggcagcct 19800
actagggacc tggggaagca aaaacgaaag ctgggcaaca tgcctgcttt agaatgtttt 19860
ccttctactt acacatcttc cacaggtctc agaatctttc cttcctctca tccttttctc 19920
ctatcttcat atctatcaga gtatccactg tttattcaac aactactact tgatggtcag 19980
acacaaacaa acaagctagg tgctaattaa taaagatacg agttttggcc gggtgcggtg 20040
gctcacgcct gtaatcccag cactttggga ggccgaggcg ggcgaatcac gaggtcagga 20100
gttcaagacc agcctggcca acatggtgaa accccatctc tactaaaaat acaaacaatt 20160
aactgagcat agtggtgggc acctataata ccagctactc cggaggctga ggcaggagaa 20220
tcgcttgaac ccaggaggca gaggttgcag tgagctgaga tcgtgccact gcactctagc 20280
cggagtgaca gagtaagact ctgtctcaaa aataaataaa taaataaata aataaataaa 20340
taaataaata aataaaaaat aataatacaa gttttcataa gcacacttct aaccccttgt 20400
cttttatgta tttccttcct tatccacgca cctgtctccc tctactccag cctcattacc 20460
ccagaggtca gtcctcagga aaactaaaca caaagaaaga gctcagtcag aaaggccatt 20520
tatttatgtt tcaagatgct cactgcctcc tttgttttgt ctcctttgca ggccttctct 20580
cttaggcctc ttctcctggg ggtatggatc ctggggggag attgatcacc tccatgcttc 20640
cattcctccc cagccatagt ggggacatca tgagagaagc caagccactg gcccaggatc 20700
acccggcatt tatggtggct gctctggcac aggtccttgc ctttatagcc cctccagtga 20760
tccataaggc cctctttctc cccaaaggag aggtcacaga tagggcaaag gtagctcttc 20820
tgcttccagt gggtctgctg gtgtctgacc agcctggaaa atgagctgaa agacttgctg 20880
caatggaagc agtagttggg cggctctgtg aggtgggcct tctggtgtct ggagagatag 20940
gatttcttgc taaaagtcaa agaacaatgg gggcaacaga agacattgag tcttgagggc 21000
ttcactggat gagagttgga tctggcatcc tgacagaggg ttccagtgat gggtgcctgg 21060
gtcctggtca caggtgcttg gttcttaagt acagatgcct ggttctgggc cataggaccc 21120
tcagttctaa atatgggttc ctgggacctg gccactggtg catggttcac atccaaaagc 21180
ccctggatgg acctctggct tctggcgatg ggtgtctgga attcagcctg ggtgcctgga 21240
atcctcaaag tacactcctg gtttccatcc actggctcct ggttttggtg tatcttctgg 21300
tggcgtttga gctcagactg gtcccggaag ctcttcccac acacagagca tgaatggggc 21360
cggtaaccca gatggacgcg gcggtgacga cttagtccag aagcatcaca gtaggtcttg 21420
tcacagagcg tgcaacagaa gggcctctcc ccaagatgca tgcgtctgtg atagctgagg 21480
gacttggggc tccgaaacaa cttcccacac tgactgcagc tgttagtcag cttgggattg 21540
tgaacaaact ggtggctata gaggtaggag cgcctgctga aacatttgcc acaggtgtag 21600
caaaaaaagg gtggcccagc ctgggatgct tgaagcaccc gggtcctgtc catagtccca 21660
gctggggcag atagggggca ctggccggcc cctctgcatg caaggaagac cttgtcatca 21720
ctagtcccct catctctcag actgggatgt tgttctcgaa gctctttctt cttgccttct 21780
acagtgaatg aggaagaata acacaaaatt cactgtaaga actccaacag aggcttggca 21840
tggtggctca cacctgtaat cccagcactt tgggaggccg aggccagcgg atcacctgag 21900
gttaggagtt cgaaaccagc ctgaccaaca tggtgaaacc ctgtctctac tacaaataca 21960
aaaattagct gggcgtcatg gcatctgcct gtaatctcag ctactaggga gactgaggca 22020
ggacaatcac tcgaacccgg gaggcggagg ttgcagtgag ccaagatggt gccactgcac 22080
tcctgcctgg gcaactagag tgaaactctg tctcaaaaaa aaaaaaagaa agaaagaaaa 22140
agaagaagaa gaaggagaag gagaagaagg agaaggagaa gagaaggaga agaagaagaa 22200
gaaggaagaa gaagaagaag aaaagaaaag aagaagaaga agaagacgaa gacgaagaag 22260
aagaagaaga ggaagaagaa gaactccaac acagcactcc attcagccta acacacttct 22320
tgtctctgcc cttgctctcc cacccaacac attcatcctt acccttgggc ctcataggct 22380
agaaataaga ag 22392

Claims (9)

1. A method for simultaneously detecting central demyelinating autoantibodies AQP4, MOG and MBP, the method comprising: respectively introducing AQP4, MOG and MBP genes into HEK293T cells, respectively incubating with a sample to be detected, detecting by an immunofluorescence method with HEK293T cells transfected with empty vectors as a control, and determining that the sample to be detected is positive if a fluorescence signal is stronger than the control; if the fluorescence signal is equal to or less than the control signal, it is negative.
2. The method of claim 1, wherein the detecting is performed by: (1) mixing the cell adherence reagent and PBS according to the volume ratio of 1:10, adding the mixture into a 6-well plate containing a cover glass, and keeping the temperature at 37 ℃ and 5% CO2Incubating for 1 hour; then adding a stable HEK293T cell line which is respectively transferred with AQP4, MOG and MBP genes, and carrying out cell culture at 37 ℃ and 5% CO2Culturing to 80% fusion degree;
(2) the cover glass with the cell surface facing upwards is stuck on a glass slide, washed by PBST, sealed by 3 percent BSA and discarded; adding the serum to be tested diluted by PBST at a volume ratio of 1:10, and adding 5% CO at 37 DEG C2Incubating for 1 hour under the condition; PBST washing; adding 50 μ l of goat anti-human IgG conjugated with biotin and streptomycin diluted by PBST at a volume ratio of 1:700, 37 deg.C, 5% CO2Incubating for 30 minutes under the condition; PBST washing; adding fluorescein 488 monthly streptomycin conjugate diluted by PBST at the volume ratio of 1:700, and washing by PBST; sealing a sheet; HEK293T cells transfected with the empty vector were used as controls under the same conditions; then, carrying out fluorescence microscope detection, and if the fluorescence signal is stronger than the contrast, determining that the sample to be detected is positive; if the fluorescence signal is equal to or less than the control signal, it is negative.
3. The method according to claim 2, wherein the cells of step (1) are inoculated in an amount of 1X 106/ml。
4. The method of claim 2, wherein in step (2) said coverslip is attached to said slide with a shadowless adhesive and fixed by ultraviolet radiation.
5. The method according to claim 2, wherein 50 μ l of the diluted test serum of step (2) is added to each well; the addition amount of goat anti-human IgG and fluorescein 488 monthly streptomycin conjugate is 50 mul/well.
6. The method according to claim 1, wherein the AQP4, MOG and MBP genes are introduced into HEK293T cells in the form of lentiviral plasmid vectors, respectively, and the nucleotide sequence of the lentiviral plasmid vector containing the AQP4 gene is shown in SEQ ID No. 1; the nucleotide sequence of the slow virus plasmid vector containing the MBP gene is shown as SEQ ID NO. 2; the nucleotide sequence of the lentiviral plasmid vector containing the MOG gene is shown in SEQ ID NO. 3.
7. The method of claim 6, wherein the AQP4 gene-containing lentiviral plasmid vector is constructed by transferring AQP4 gene into a plasmid vector pCDH-CMV-MCS-EGFP.
8. The method of claim 6, wherein the MBP gene-containing lentiviral plasmid vector is constructed by transforming the MBP gene into a plasmid vector pCDH-CMV-MCS-EGFP.
9. The method of claim 6, wherein the lentiviral plasmid vector containing the MOG gene is constructed by transferring the MOG gene into a plasmid vector pCDH-CMV-MCS-EGFP.
CN202010021551.1A 2020-01-09 2020-01-09 Method for simultaneously detecting central demyelinating autoantibodies AQP4, MOG and MBP Pending CN111272998A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010021551.1A CN111272998A (en) 2020-01-09 2020-01-09 Method for simultaneously detecting central demyelinating autoantibodies AQP4, MOG and MBP

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010021551.1A CN111272998A (en) 2020-01-09 2020-01-09 Method for simultaneously detecting central demyelinating autoantibodies AQP4, MOG and MBP

Publications (1)

Publication Number Publication Date
CN111272998A true CN111272998A (en) 2020-06-12

Family

ID=71000137

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010021551.1A Pending CN111272998A (en) 2020-01-09 2020-01-09 Method for simultaneously detecting central demyelinating autoantibodies AQP4, MOG and MBP

Country Status (1)

Country Link
CN (1) CN111272998A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112362877A (en) * 2020-10-27 2021-02-12 江苏先声医学诊断有限公司 MBP recombinant protein and application thereof
CN113481166A (en) * 2021-07-08 2021-10-08 刘佳 Cryopreserved cell model construction and detection method for immediately detecting MOG-IgG level in serum
CN115232795A (en) * 2021-07-22 2022-10-25 北京和合医学诊断技术股份有限公司 Cell strain for stably expressing AQP4-M23 protein and construction method and application thereof

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1910456A (en) * 2003-11-25 2007-02-07 马约医学教育与研究基金会 Marker for neuromyelitis optica
US20130323754A1 (en) * 2011-02-15 2013-12-05 Euroimum Medizinische Labordiagnostika Diagnostic Kit as Well as a Metho dfor the Examination of a Human Patient Sample for the Presence of Neuromyelitis Optica-Specific Antibodies
CN103937836A (en) * 2014-04-04 2014-07-23 天津医科大学总医院 Detection method of aquaporin-4 autoantibody, fusion expression virus vector and application thereof
US20140255346A1 (en) * 2011-05-04 2014-09-11 Cellular Technology, Ltd. Cns antigen-specific b cell, t cell and antibody assays and their uses in diagnosis and treatment of multiple sclerosis
US20150140569A1 (en) * 2012-10-31 2015-05-21 Jun Xu ELISpot diagnostic kit for neuromyelitis optica and its application
US20150355177A1 (en) * 2014-06-06 2015-12-10 Euroimmun Medizinische Labordiagnostika Ag Diagnosis of a neurological disease
US20170080063A1 (en) * 2014-05-19 2017-03-23 The Johns Hopkins University Highly soluble aquaporin-4 extracellular loop c peptide immunization for treatment of neuromyelitis optica
CN107271680A (en) * 2017-05-22 2017-10-20 广州基迪奥生物科技有限公司 Method for detecting autoimmune antibody of human myelin oligodendrocyte glycoprotein
CN107299111A (en) * 2017-06-21 2017-10-27 中国人民解放军总医院 Detect the preparation of cell climbing sheet component, CBA detection kits and its application of MOG IgG CBA kits
CA2933793A1 (en) * 2016-06-21 2017-12-21 Euroimmun Medizinische Labordiagnostika Ag Methods, products and uses for the diagnosis of a neuroautoimmune disease by detecting autoantibodies to flotillin1 and/or flotillin2
WO2018127585A1 (en) * 2017-01-06 2018-07-12 Txcell Monospecific regulatory t cell population with cytotoxicity for b cells

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1910456A (en) * 2003-11-25 2007-02-07 马约医学教育与研究基金会 Marker for neuromyelitis optica
US20130323754A1 (en) * 2011-02-15 2013-12-05 Euroimum Medizinische Labordiagnostika Diagnostic Kit as Well as a Metho dfor the Examination of a Human Patient Sample for the Presence of Neuromyelitis Optica-Specific Antibodies
US20140255346A1 (en) * 2011-05-04 2014-09-11 Cellular Technology, Ltd. Cns antigen-specific b cell, t cell and antibody assays and their uses in diagnosis and treatment of multiple sclerosis
US20190072551A1 (en) * 2011-05-04 2019-03-07 Cellular Technology Limited CNS Antigen-Specific B Cell and Antibody Assays in Multiple Sclerosis
US20150140569A1 (en) * 2012-10-31 2015-05-21 Jun Xu ELISpot diagnostic kit for neuromyelitis optica and its application
CN103937836A (en) * 2014-04-04 2014-07-23 天津医科大学总医院 Detection method of aquaporin-4 autoantibody, fusion expression virus vector and application thereof
US20170080063A1 (en) * 2014-05-19 2017-03-23 The Johns Hopkins University Highly soluble aquaporin-4 extracellular loop c peptide immunization for treatment of neuromyelitis optica
US20150355177A1 (en) * 2014-06-06 2015-12-10 Euroimmun Medizinische Labordiagnostika Ag Diagnosis of a neurological disease
CA2933793A1 (en) * 2016-06-21 2017-12-21 Euroimmun Medizinische Labordiagnostika Ag Methods, products and uses for the diagnosis of a neuroautoimmune disease by detecting autoantibodies to flotillin1 and/or flotillin2
WO2018127585A1 (en) * 2017-01-06 2018-07-12 Txcell Monospecific regulatory t cell population with cytotoxicity for b cells
CN107271680A (en) * 2017-05-22 2017-10-20 广州基迪奥生物科技有限公司 Method for detecting autoimmune antibody of human myelin oligodendrocyte glycoprotein
CN107299111A (en) * 2017-06-21 2017-10-27 中国人民解放军总医院 Detect the preparation of cell climbing sheet component, CBA detection kits and its application of MOG IgG CBA kits

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
ARISTO VOJDANI ET AL.: "Detection of Antibodies against Human and Plant Aquaporins in Patients with Multiple Sclerosis", pages 1 - 10 *
COTT S. ZAMVIL,ANTHONY J. SLAVIN: "Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?", pages 1 - 9 *
NAKAJIMA H, ET AL.: "Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis", pages 1 - 4 *
T. LIU ET AL.: "Screening for autoantibodies in inflammatory neurological syndrome using fluorescence pattern in a tissue-based assay: Cerebrospinal fluid findings from 793 patients", pages 177 *
TOBIAS DERFUSS AND EDGAR MEINL: "Identifying autoantigens in demyelinating diseases: valuable clues to diagnosis and treatment?", vol. 25, no. 25, pages 231 - 238 *
张莉莉,朱 洁: "神经***自身免疫性疾病的抗体检测及临床意义", vol. 17, no. 17, pages 396 - 402 *
秦新月等: "从分子免疫病理学的角度看视神经脊髓炎 谱系疾病诊断标准的演变", vol. 42, no. 42, pages 672 - 675 *
郭艳芹,郭晓玲主编;王伊龙,刘秋庭,钟镝副主编;王玉芬等编: "《实用现代医学 下 神经内科学》", 石家庄:河北科学技术出版社, pages: 207 - 334 *
黄清清: "视神经脊髓炎谱系疾病相关视神经炎的临床分析", 《中国优秀硕士学位论文全文数据库医药卫生科技辑》, pages 6 - 11 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112362877A (en) * 2020-10-27 2021-02-12 江苏先声医学诊断有限公司 MBP recombinant protein and application thereof
CN112362877B (en) * 2020-10-27 2024-04-12 江苏先声医学诊断有限公司 MBP recombinant protein and application thereof
CN113481166A (en) * 2021-07-08 2021-10-08 刘佳 Cryopreserved cell model construction and detection method for immediately detecting MOG-IgG level in serum
CN115232795A (en) * 2021-07-22 2022-10-25 北京和合医学诊断技术股份有限公司 Cell strain for stably expressing AQP4-M23 protein and construction method and application thereof
CN115232795B (en) * 2021-07-22 2023-09-19 北京和合医学诊断技术股份有限公司 Cell strain for stably expressing AQP4-M23 protein, construction method and application thereof

Similar Documents

Publication Publication Date Title
KR102630017B1 (en) Programmed death 1 ligand 1 (PD-L1) binding protein and methods of use thereof
CN110656090B (en) Expression plasmid, cell strain for packaging capacity-increased second-generation adenovirus and application of cell strain
KR102049623B1 (en) Multiplex immuno screening assay
CN111272998A (en) Method for simultaneously detecting central demyelinating autoantibodies AQP4, MOG and MBP
CN107098969B (en) A kind of recombination structure of Chimeric antigen receptor that treating HIV infection and its application
KR20190082241A (en) Anti-BCMA CAR T cell composition
CA2545755A1 (en) Plasmid system for multigene expression
CN111089972B (en) Kit for detecting anti-human myelin basic protein antibody and application thereof
US11820998B2 (en) Porcine Thy1 gene promoter specifically expressed in neurons
CN112458058B (en) TRAF6 over-expression DC cell, DC cell vaccine, construction method and application
AU2021391330A1 (en) Stable lentivirus packaging cell line and preparation method therefor
CN113186167B (en) Method for determining biological activity of anti-CD 20 monoclonal antibody drug ADCP
CN112626127B (en) Recombinant lentiviral vector and preparation method and application thereof
CN112226444A (en) Nucleotide sequence of fusion glycoprotein before full-length fusion of respiratory syncytial virus, recombinant adenovirus vector and application product thereof
KR20190076992A (en) A manipulated multicomponent system for the identification and characterization of T-cell receptors, T-cell antigens and their functional interactions
CN108059675B (en) Construction of recombinant PG9-CAR molecule and application thereof in eliminating HIV-1 infected cells
CN109097392A (en) A kind of Her2-CAR-T system constituting method based on PiggyBac carrier
CN112522205B (en) Cell line for over-expressing angiotensin converting enzyme 2 as well as preparation method and application thereof
AU2022257301A1 (en) Casrx/cas13d systems targeting c9orf72
WO2022241455A1 (en) A synthetic circuit for buffering gene dosage variation between individual mammalian cells
CN113355295A (en) Recombinant oncolytic newcastle disease virus expressing human GM-CSF and application thereof
CN108070033A (en) A kind of structure of 3BNC-CAR molecules and its application in HIV-1 infection cells are killed
CN114085868A (en) Targeting vector, recombinant Huh7 cell line, construction method and application
CN109957551A (en) Express vaccinia virus recombinant and its application of people&#39;s beta-alexin 2
CN114107384A (en) Vector targeting EML4-ALK fusion gene variant 1 in human non-small cell lung cancer cell strain and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200612